asthma
common
debilit
diseas
substanti
increas
preval
western
societi
last
decad
respiratori
tract
infect
respiratori
syncyti
viru
rsv
rhinoviru
rv
wide
implic
common
caus
induct
exacerb
asthma
infect
earli
life
associ
induct
wheez
may
progress
develop
asthma
infect
may
also
promot
airway
inflamm
enhanc
helper
type
lymphocyt
cell
respons
result
exacerb
establish
asthma
mechan
rsv
rv
induc
exacerb
asthma
current
elucid
clinic
studi
vitro
work
human
cell
anim
model
diseas
research
led
mani
potenti
therapeut
strategi
although
none
yet
part
clinic
practis
show
much
promis
prevent
treatment
viral
diseas
subsequ
asthma
introduct
asthma
thought
affect
least
million
peopl
age
ethnic
background
worldwid
global
strategi
asthma
manag
prevent
peopl
affect
western
societi
preval
doubl
sinc
umetsu
et
al
aihw
consid
epidem
result
massiv
econom
burden
commun
exacerb
typic
caus
exposur
environment
factor
individu
allerg
although
asthma
clearli
recognis
inflammatori
condit
understand
mechan
pathogenesi
remain
rudimentari
clinic
asthma
characteris
airway
obstruct
wheez
episod
breathless
associ
increas
sensit
airway
nonspecif
stimuli
term
airway
hyperrespons
ahr
bousquet
et
al
wheez
highpitch
whistl
squeak
origin
chest
made
breath
michel
et
al
predomin
featur
diseas
acuteonchron
infiltr
proinflammatori
activ
cell
eosinophil
airway
critic
regul
pathogenesi
robinson
et
al
kay
typic
pathogen
featur
includ
ige
product
airway
smooth
tabl
import
factor
releas
respiratori
epithelium
upon
viral
infect
dakhama
et
al
nitric
oxid
muscl
asm
goblet
cell
hypertrophyhyperplasia
mucu
hypersecret
eosinophil
neutrophil
mononuclear
cell
infiltr
submucos
layer
airway
mast
cell
macrophag
activ
slough
airway
epitheli
cell
ahr
foster
et
al
kumar
cohn
et
al
cell
activ
inflammatori
cell
releas
rang
mediat
damag
mucos
epitheli
line
promot
exagger
repair
respons
lead
airway
remodel
chronic
diseas
remodel
result
structur
chang
epithelium
submucos
layer
asm
vasculatur
angiogenesi
bousquet
et
al
vignola
et
al
thought
major
contribut
factor
develop
ahr
progress
may
lead
fix
airflow
obstruct
irrevers
loss
lung
function
li
wilson
vignola
et
al
thu
airway
inflamm
close
link
ahr
airflow
obstruct
recur
inflammatori
insult
may
result
chang
lead
airway
remodel
mechan
respons
gener
inflamm
remodel
remain
poorli
understood
may
induc
exacerb
respiratori
viral
infect
respiratori
infect
rsv
rv
influenza
parainfluenza
metapneumoviru
mpv
implic
develop
asthma
well
exacerb
infect
rsv
rv
far
wide
commonli
associ
bronchiol
childhood
wheez
induct
exacerb
asthma
papadopoulo
et
al
xepapadaki
et
al
rsv
may
caus
earlier
sever
exacerb
frequent
link
induct
asthma
wherea
rv
common
caus
exacerb
later
life
zhao
et
al
whether
infect
induc
diseas
depend
viral
type
eg
rsv
rv
host
genet
suscept
age
immun
respons
environment
allergen
exposur
season
factor
initi
infect
occur
inhal
spread
lower
respiratori
tract
lrt
infect
larg
restrict
respiratori
epithelium
induc
releas
wide
rang
mediat
tabl
dakhama
et
al
drive
subsequ
immun
physiolog
respons
specif
viru
fig
rsv
rv
import
caus
lrt
infect
infant
year
caus
bronchiol
result
wheez
breath
difficulti
may
sever
case
result
hospit
sigur
et
al
kotaniemisyrjanen
et
al
henderson
et
al
sigur
et
al
asthmat
may
suscept
viral
infect
lead
sever
lrt
symptom
associ
increas
hospit
corn
et
al
notabl
commonest
caus
asthma
relateddeath
respiratori
viral
infect
mccann
imani
sever
bronchiol
result
hospit
shown
associ
fig
rsv
rv
asthma
therapi
rsv
attach
invad
respiratori
epithelium
attach
g
fusion
f
protein
major
minor
group
rv
bind
ldlpr
respiratori
epithelium
respect
induc
viral
internalis
upregul
addit
receptor
upon
invas
viral
prolifer
lead
induct
inflammatori
cell
mediat
enhanc
allergen
penetr
hallmark
featur
asthma
includ
inflamm
wheez
airway
obstruct
ahr
may
induc
develop
exacerb
asthma
variou
process
virusassoci
asthma
may
target
therapeut
case
control
studi
histori
recurr
wheez
diagnosi
asthma
later
childhood
sigur
et
al
sigur
et
al
rsv
wide
implic
precipit
recent
studi
suggest
rv
may
also
import
particularli
age
heymann
et
al
method
detect
constantli
improv
facilit
elucid
role
virus
asthma
pierang
et
al
mechan
underpin
virusinduc
induct
exacerb
asthma
factor
respons
predispos
individu
remain
poorli
understood
unclear
whether
virusinduc
bronchiol
promot
develop
asthma
individu
suffer
sever
infect
also
suscept
asthma
develop
result
genet
suscept
includ
atopi
aberr
lung
function
understand
mechan
pathogen
respiratori
viral
infect
associ
asthma
pivot
develop
prevent
treatment
strategi
asthma
inde
may
possibl
identifi
risk
individu
delay
infect
later
life
develop
novel
therapeut
agent
target
asthma
trigger
chronic
inflammatori
process
airway
inflamm
mucu
hypersecret
overzeal
respons
asthmat
immun
system
normal
innocu
antigen
infect
recurr
stimul
lead
airway
remodel
respiratori
viral
infect
induc
immun
respons
may
potenti
initi
exacerb
asthma
collect
evid
strongli
implic
respiratori
viral
infect
develop
asthmat
phenotyp
children
although
directli
caus
role
still
proven
possibl
either
respiratori
infect
earli
life
induc
develop
chronic
airway
inflamm
airway
wall
remodel
result
persist
wheez
infant
preexist
respons
induc
suscept
virusinduc
wheez
legg
et
al
stensbal
et
al
evid
virusinduc
asthma
exacerb
stronger
causat
infect
respons
major
acut
exacerb
children
adult
induc
worsen
airflow
obstruct
symptom
wark
et
al
murray
et
al
tan
determin
viru
infect
directli
influenc
diseas
acut
asthma
exacerb
wark
et
al
recruit
adult
present
emerg
acut
asthma
determin
subject
evid
viral
infect
wark
et
al
compar
subject
noninfect
acut
asthma
acut
asthma
infect
evid
sever
clinic
diseas
lower
mean
forc
expiratori
volum
fev
predict
like
admit
hospit
longer
median
length
stay
acut
neutrophil
infiltr
observ
induc
sputum
evid
neutrophil
degranul
unlik
eosinophil
inflamm
associ
noninfect
asthma
wark
et
al
addit
lactat
dehydrogenas
measur
marker
asthmat
airway
necrosi
virusassoci
acut
asthma
significantli
elev
lactat
dehydrogenas
activ
correl
close
degre
neutrophil
influx
airflow
obstruct
independ
predictor
sever
acut
ill
result
strongli
implic
viral
infect
trigger
exacerb
increas
sever
indic
import
role
virus
modifi
inflamm
acut
asthma
wark
et
al
mani
differ
categori
phenotyp
asthma
includ
mild
moder
sever
well
clinic
allerg
pathophysiolog
phenotyp
wenzel
recent
simpson
et
al
describ
differ
inflammatori
neutrophil
eosinophil
paucigranulocyt
subtyp
asthma
base
predomin
granulocyt
cell
induc
sputum
simpson
et
al
precis
role
respiratori
viral
infect
develop
exacerb
differ
phenotyp
asthma
remain
larg
unknown
howev
potenti
viral
infect
may
particularli
import
certain
phenotyp
differ
customis
prevent
treatment
strategi
may
requir
differ
phenotyp
depend
caus
target
antivir
strategi
may
effect
certain
asthma
phenotyp
exampl
sever
neutrophil
asthma
infecti
agent
may
play
substanti
role
pathogenesi
wark
et
al
mani
factor
may
involv
suscept
virusinduc
asthma
particularli
viru
host
factor
viru
infect
commonest
caus
wheez
children
may
lead
develop
asthma
heymann
et
al
time
year
also
play
role
winter
domin
period
viral
infect
wheez
heymann
et
al
genet
predisposit
may
import
mani
gene
implic
suscept
asthma
includ
involv
inflammatori
respons
ige
regul
cytokin
chemokin
product
airway
function
remodel
umetsu
et
al
atopi
may
lead
advers
respons
infect
childhood
wheez
link
elev
ige
sensit
least
one
inhal
allergen
howev
genet
western
popul
experienc
asthma
epidem
remain
unchang
focu
review
import
factor
associ
rsvand
rvassoci
asthma
includ
age
infect
time
infect
rel
allergen
exposur
increas
innat
suscept
adapt
immun
cytokin
chemokin
respons
well
environment
condit
inhal
bacteri
endotoxin
rsv
lipidenvelop
singl
strand
ss
neg
sens
rna
pneumoviru
member
paramyxovirida
famili
viru
caus
major
case
bronchiol
ng
hansbro
et
al
pharmacolog
therapeut
examin
effect
differ
clinic
characterist
treatment
hospit
infant
bronchiol
outpati
clinic
infant
year
present
episod
wheez
retrospect
analysi
medic
record
patient
rsv
hospit
vs
without
rsv
children
expos
tobacco
smoke
hospit
often
vs
expos
treatment
oral
corticosteroid
associ
fewer
hospit
famili
histori
asthmaallerg
rhiniti
vs
without
rsv
vs
al
shawwa
rao
earli
life
may
induc
wheez
may
develop
asthma
also
major
precipit
asthma
exacerb
epidemiolog
rsv
import
respiratori
pathogen
children
age
year
primari
infect
common
caus
lrt
diseas
hall
henrickson
et
al
major
infant
infect
first
year
life
incid
exposur
approach
age
parrott
et
al
glezen
et
al
hall
et
al
infect
frequent
caus
bronchiol
also
induc
pneumonia
tracheobronch
annual
epidem
primarili
infant
hall
around
children
hospit
result
bronchiti
annual
usa
less
month
less
year
age
estim
cost
million
per
year
shay
et
al
hospit
bronchiol
dramat
increas
last
year
shay
et
al
may
result
chang
childcar
practis
gener
decreas
immun
popul
mortal
rate
primari
infect
healthi
hospit
children
ruuskanen
ogra
chanock
et
al
children
contract
sever
rsv
diseas
identifi
risk
factor
except
prematur
birth
infect
also
caus
sever
diseas
elderli
immunocompromis
mild
upper
rt
urt
symptom
rhinorrhea
nasal
blockag
pharyng
cough
occur
age
falsey
walsh
englund
et
al
reinfect
also
common
occur
everi
year
throughout
life
usual
result
mild
urt
symptom
importantli
result
lack
develop
longterm
resist
rsv
infect
immun
system
bont
et
al
major
symptom
result
host
immun
inflammatori
respons
infect
openshaw
reinfect
induc
sustain
exacerb
inflammatori
reaction
pathogenesi
upon
rsv
infect
interact
viru
respiratori
mucos
surfac
viral
g
protein
mediat
attach
f
protein
induc
fusion
viral
envelop
cytoplasm
membran
host
cell
result
internalis
fig
invas
viral
ssrna
releas
cytoplasm
induc
product
viral
rna
protein
induc
inflammatori
respons
rsv
protein
function
recent
review
meyer
et
al
outcom
inflammatori
respons
develop
symptom
pathogen
infect
typic
rsv
infect
human
restrict
mucos
epitheli
cell
urt
caus
runni
nose
nasal
congest
cough
hall
et
al
sever
rsv
infect
viru
spread
lrt
result
sever
symptom
vitro
studi
human
infect
well
autopsi
sampl
infant
children
acut
rsv
infect
show
viral
replic
airway
epitheli
cell
particularli
superfici
layer
bronchiolar
epithelium
well
type
pneumocyt
infect
induc
gener
inflammatori
mediat
mononuclear
inflammatori
respons
plug
bronchiol
mucu
cellular
debri
fibrin
strand
well
necrosi
bronchiolar
epithelium
piedra
et
al
johnson
et
al
lack
cytopatholog
infect
implic
inflammatori
respons
pivot
driver
rsvinduc
diseas
zhang
et
al
inflammatori
cell
consist
mainli
monocyt
cell
neutrophil
accumul
around
bronchial
pulmonari
arteriol
airway
parenchyma
associ
edema
mucu
product
wheez
airway
obstruct
ahr
induct
diseas
process
may
involv
develop
exacerb
asthma
clinic
epidemiolog
studi
shown
rsv
infect
associ
rapid
increas
incid
asthma
paediatr
adult
popul
worldwid
wang
forsyth
tan
infect
also
one
commonest
caus
asthma
exacerb
recent
epidemiolog
studi
link
rsv
asthma
shown
tabl
older
studi
review
ogra
rsv
infect
import
risk
factor
develop
bronchiol
lead
recurr
wheez
respiratori
symptom
decreas
lung
function
recurr
wheez
allerg
rhinoconjunct
howev
yet
conclus
demonstr
virusinduc
symptom
progress
develop
asthma
link
infect
atopi
sensit
common
inhal
allergen
skin
prick
test
spt
ige
also
investig
result
inconclus
asthmat
may
prone
sever
infect
may
prognost
indic
allerg
suscept
case
childhood
hospit
bronchiol
attribut
rsv
infect
holberg
et
al
collect
studi
show
rsvinduc
bronchiol
diseas
small
airway
often
lead
wheez
frequent
progress
asthma
review
heymann
et
al
mani
studi
report
subject
rsv
bronchiol
suffer
subsequ
recurr
wheez
respiratori
symptom
year
later
review
ogra
import
prospect
studi
stein
et
al
show
children
one
lrt
rsv
infect
time
like
frequent
wheez
age
howev
associ
decreas
thereaft
nonsignific
age
stein
et
al
anoth
smaller
prospect
studi
demonstr
sever
rsv
bronchiol
link
current
wheez
reactiv
airway
diseas
rad
compar
uninfect
control
respect
match
age
sex
famili
histori
environ
sigur
et
al
control
retrospect
prospect
studi
indic
link
rsv
bronchial
obstruct
decreas
lung
function
particularli
children
sever
rsv
diseas
result
hospit
review
sigur
inde
bronchiol
link
chronic
reduct
lung
function
least
year
infect
pullan
hey
children
hospit
rsv
infect
year
age
reduc
lung
function
asthma
year
later
korppi
et
al
furthermor
airway
obstruct
ahr
increas
rsv
bronchiol
compar
control
sigur
nest
casecontrol
studi
also
show
rsvinduc
hospit
correl
wheez
lrt
infect
asthma
first
year
life
correl
decreas
age
signific
year
associ
held
increas
respiratori
symptom
chronic
product
cough
year
alaska
nativ
children
singleton
et
al
stein
studi
wheez
subject
significantli
respons
bronchodil
indic
reduc
lung
function
result
abnorm
airway
tone
stein
et
al
rsv
bronchiol
particularli
earli
life
strongli
link
develop
asthma
inde
children
bronchiol
develop
wheez
asthma
versu
vs
vs
even
year
later
sli
hibbert
sigur
et
al
larouch
et
al
sigur
et
al
ogra
recent
studi
found
children
hospit
rsv
increas
risk
recurr
wheez
age
year
independ
atopi
asthma
risk
factor
identifi
rsv
infect
potenti
induc
asthma
inde
subject
significantli
respiratori
symptom
vs
asthmarecurr
wheez
sensit
common
allergen
vs
spt
vs
serum
ige
airway
obstruct
ahr
age
year
compar
control
sigur
et
al
recent
report
also
shown
rsv
infect
associ
concomit
respiratori
symptom
wheez
subsequ
asthma
year
age
high
rate
rsv
isol
children
recurr
wheez
asthma
lazzaro
et
al
lee
et
al
associ
confirm
longitudin
cohort
studi
may
depend
individu
airway
structur
genet
predisposit
environment
factor
review
martinez
may
link
atopi
rsv
infect
wheez
sigur
et
al
risk
factor
may
includ
sever
rsv
infect
encount
atop
children
low
respons
cord
blood
elev
respons
compar
nonatop
atop
adult
also
respons
allergen
wherea
nonatop
lowlevel
respons
ogra
elev
express
respons
may
promot
suscept
rsv
infect
may
also
lead
exagger
airway
inflamm
reduc
lung
function
howev
link
rsv
infect
atopi
controversi
found
studi
stein
et
al
kneyber
et
al
earli
rsv
infect
first
year
may
induc
allerg
sensit
unrel
antigen
genet
predispos
individu
sigur
et
al
forster
et
al
inde
rsv
bronchiol
first
year
life
lead
increas
ige
level
vs
control
import
risk
factor
allerg
sensit
recurr
wheez
vs
control
schauer
et
al
furthermor
allerg
sensit
asthma
significantli
common
age
group
children
prior
rsv
bronchiol
vs
vs
control
respect
sigur
appear
sever
infect
may
import
sever
infect
associ
develop
allerg
sensit
year
hospit
sigur
et
al
sigur
et
al
mild
infect
appear
risk
factor
allerg
sensit
stein
et
al
sigur
et
al
howev
data
conflict
sever
infect
shown
induc
sensit
age
year
investig
pullan
hey
carlsen
et
al
nobl
et
al
preexist
impair
respons
asthmat
predisposit
may
promot
suscept
acut
bronchiol
hospit
rsv
infect
legg
et
al
stensbal
et
al
furthermor
individu
damag
airway
epithelium
otherwis
immunolog
predispos
may
addit
suscept
infect
enhanc
epitheli
damag
caus
viciou
cycl
diseas
perpetu
although
rsv
infect
extens
link
induc
asthma
reduc
lung
function
possibl
infect
also
marker
suscept
allerg
andor
infecti
respiratori
diseas
shown
although
rsv
infect
greatest
risk
factor
wheez
asthma
subject
famili
histori
asthma
asthma
develop
without
infect
famili
histori
sigur
et
al
sigur
indic
rsv
bronchiol
marker
increas
risk
asthma
suscept
recent
suggest
host
respons
infect
rather
natur
infect
best
prognost
indictor
subsequ
allerg
diseas
everard
everard
atopi
may
also
risk
factor
suscept
sever
rsv
infect
exacerb
result
higher
rate
mortal
hospit
jhawar
larg
nest
casecontrol
studi
demonstr
matern
atop
dermat
matern
patern
asthma
rr
respect
risk
factor
rsv
hospit
infant
year
stensbal
et
al
taken
togeth
studi
show
rsv
infect
earli
life
result
bronchiol
lead
wheez
decreas
lung
function
may
progress
asthma
process
may
enhanc
atop
individu
elev
respons
moreov
evid
although
conclus
sever
infect
may
also
promot
sensit
allergen
may
increas
risk
wheez
asthma
asthmat
may
suscept
sever
infect
may
use
indictor
suscept
develop
asthma
experiment
rsv
infect
human
use
investig
mechan
pathogenesi
infecti
diseas
associ
asthma
studi
demonstr
viru
persist
nasal
wash
day
noah
becker
infect
induc
bronchiol
airway
inflamm
promot
epitheli
slough
mucu
hypersecret
increas
viscos
edema
turn
lead
hyperinfl
lung
airflow
obstruct
cough
wheez
holt
sli
symptom
may
persist
resolut
tissu
damag
may
take
sever
week
result
structur
remodel
airway
wall
airway
narrow
pare
et
al
holt
sli
mechan
rsv
pathogenesi
lead
wheez
ahr
allergi
asthma
still
well
understood
mani
studi
implic
rang
differ
factor
includ
age
first
infect
type
innat
adapt
respons
elicit
mucos
damag
repair
involv
remodel
includ
angiogenesi
enhanc
neurogen
stimul
lead
asm
spasm
bronchoconstrict
accord
hygien
hypothesi
strachan
immun
system
newborn
must
encount
agent
childhood
order
develop
abil
mount
respons
howev
whether
infect
infanc
induc
benefici
respons
depend
upon
type
infect
mechan
respons
effect
characteris
thu
immatur
develop
immun
system
earli
life
natur
immun
respons
infect
may
signific
determin
factor
develop
persist
wheez
asthma
whether
rsv
infect
induc
immunolog
patholog
process
may
lead
asthma
may
depend
age
individu
first
infect
immun
phenotyp
earli
life
may
lead
enhanc
viral
replic
inflamm
induc
infect
allergen
exposur
increas
level
detect
rsv
infect
infant
less
month
old
compar
month
convers
true
eotaxin
differ
eosinophil
cation
protein
ecp
kristjansson
et
al
mother
infect
induc
high
level
low
level
wherea
newborn
infant
produc
time
less
higher
level
age
level
approach
mother
mbawuik
et
al
immun
respons
earli
life
may
involv
induct
sever
lrt
patholog
respons
primari
infect
infect
older
children
sever
involv
larg
urt
symptom
addit
patholog
consequ
viral
infect
earli
life
may
gener
pulmonari
inflamm
develop
lung
small
larg
airway
immun
inflammatori
neuron
program
review
gern
et
al
may
result
alter
pulmonari
structur
immun
respons
lead
enhanc
proinflammatori
immun
respons
may
precipit
deleteri
chang
lung
structur
function
furthermor
small
size
neonat
bronchiol
determin
may
becom
obstruct
readili
may
result
reduc
clearanc
confer
enhanc
sever
pathogen
infect
age
group
combin
event
may
longterm
effect
lung
function
chronic
respiratori
inflamm
remodel
alveolar
epitheli
dysfunct
gern
et
al
consequ
may
promot
develop
asthma
howev
whether
rsv
infect
induc
respons
human
earli
life
debat
anoth
altern
explan
associ
rsv
infect
infanc
asthma
earli
life
infect
induc
memori
therefor
ctl
respons
potenti
induc
patholog
immun
respons
reinfect
rsv
infect
induc
viral
specif
cell
infant
level
cytotox
lymphocyt
ctl
invers
proport
respons
ctl
respons
directli
link
protect
infect
ctl
memori
initi
upon
reinfect
mhc
level
correl
directli
level
mbawuik
et
al
immun
respons
induc
rsv
enhanc
viral
clearanc
also
implic
diseas
pathogenesi
ineffect
aberr
innat
adapt
immun
respons
rsv
wide
link
sever
recur
infect
develop
exacerb
asthma
adult
children
glezen
et
al
hall
et
al
primari
infect
particularli
earli
life
lead
incomplet
immun
respons
elicit
develop
sustain
memori
immun
respect
allergi
rsv
infect
might
trigger
defect
immun
genet
suscept
individu
allerg
inflammatori
immun
respons
may
promot
influx
virusspecif
cell
airway
increas
inflamm
ahr
schwarz
et
al
elucid
pivot
immun
respons
protect
rsv
lead
better
understand
process
result
bronchiol
wheez
progress
asthma
innat
respons
rsv
infect
wide
studi
may
play
import
role
rsvinduc
asthma
rsv
infect
respiratori
epithelium
induc
innat
cellular
cytokin
respons
substanti
effect
adapt
cell
develop
cellmedi
immun
respons
neutrophil
main
immun
cell
bronchoalveolar
lavag
fluid
balf
patient
sever
rsv
lrt
diseas
increas
level
potent
chemoattractor
neutrophil
also
promin
featur
macrophag
internalis
process
viru
present
antigen
adapt
immun
cell
also
releas
monocyt
releas
plateletactiv
factor
paf
exposur
rsv
promot
proinflammatori
respons
schaller
et
al
eosinophil
also
recruit
airway
primari
rsv
infect
may
contribut
develop
allerg
airway
diseas
schwarz
et
al
infect
patient
also
plasmacytoid
dendrit
cell
pdc
myeloid
dc
mdc
rt
reduc
number
cell
circul
blood
gill
et
al
suggest
recruit
lung
infect
may
import
target
rsv
vaccin
develop
understand
interplay
differ
cell
type
crucial
elucid
effect
infect
develop
asthma
import
type
ifn
innat
cytokin
releas
upon
viral
infect
induc
innat
adapt
cellular
respons
blood
cultur
asthmat
children
adult
releas
significantli
reduc
amount
upon
rsv
infect
indic
system
innat
defici
asthmat
may
lead
heighten
suscept
infect
gehlhar
et
al
respons
rsv
sever
cell
epitop
infect
induc
adapt
cellular
respons
well
proand
antiinflammatori
cytokin
chemokin
human
vivo
vitro
meyer
et
al
establish
infect
primarili
clear
combin
cell
respons
balanc
two
may
crucial
determin
outcom
infect
sever
rsvinduc
diseas
predisposit
asthma
aberr
respons
either
subset
may
induc
patholog
nevertheless
studi
suggest
respons
may
result
viral
clearanc
mild
symptom
wherea
aberr
bia
toward
phenotyp
may
lead
intens
rsvinduc
diseas
promot
develop
asthma
inde
individu
elev
respons
predispos
reduc
viral
clearanc
sever
diseas
compar
subject
urt
infect
independ
age
viral
load
roman
et
al
aberl
et
al
legg
et
al
gern
et
al
earli
life
rsv
bronchiol
result
enhanc
respons
rsv
later
childhood
pala
et
al
import
stimulu
develop
ige
product
respons
enhanc
sever
diseas
develop
upon
natur
infect
rsvvaccin
infant
kim
et
al
kapikian
et
al
sever
rsv
bronchiol
correl
elev
humor
respons
may
link
atopi
increas
reduc
respons
rsv
infect
may
also
persist
immunolog
effect
induc
longterm
memori
respons
sensit
inhal
allergen
childhood
holt
sli
van
rijt
et
al
studi
demonstr
mild
bronchiol
associ
shift
toward
respons
usual
individu
also
increas
respons
sever
bronchiol
contrast
result
may
attribut
differ
time
sampl
infect
lack
definit
detect
rsv
determin
viru
load
age
atop
statu
individu
cytokin
immunomodulatori
molecul
cytokin
regulatori
type
implic
rsvinduc
asthma
effect
proinflammatori
cytokin
chemokin
releas
respons
infect
may
particularli
import
role
cytokin
upregul
children
acut
asthma
children
acut
bronchiol
level
higher
number
eosinophil
martinez
respons
may
play
key
role
progress
bronchiol
asthma
howev
import
eosinophil
rsvinduc
asthma
yet
confirm
cytokin
promot
develop
cell
releas
natur
killer
nk
cell
suppress
respons
level
may
reduc
subject
suscept
infect
nonspecif
stimul
whole
blood
cultur
patient
rsv
diseas
releas
significantli
less
control
level
invers
correl
diseas
sever
bont
et
al
respons
suppress
acut
rsv
diseas
return
control
level
convalesc
level
differ
subsequ
wheez
infant
bont
et
al
reduc
level
may
lead
elev
suscept
respons
rsv
infect
predisposit
asthma
regulatori
cytokin
may
promot
asthma
phenotyp
suppress
cytokin
product
antigen
present
promot
enhanc
suscept
infect
respons
induc
wheez
proasthmat
respons
subsequ
antigen
challeng
bont
et
al
bont
et
al
level
chang
acut
rsv
diseas
increas
convalesc
significantli
higher
subsequ
wheezer
went
develop
recurr
wheez
asthma
thu
enhanc
inhibit
product
upon
rsv
infect
may
suppress
immun
function
permit
sever
infect
diseas
progress
also
suggest
rsv
infect
may
chang
enhanc
profil
proinflammatori
cytokin
chemokin
releas
promot
sever
infect
alter
natur
cell
respons
promot
allergi
inflamm
patient
rsvinduc
bronchiol
elev
level
rant
correl
diseas
sever
nasopharyng
secret
rant
ige
serum
sung
et
al
garofalo
et
al
garofalo
et
al
furthermor
treatment
human
epitheli
cell
play
pivot
role
airway
remodel
asthma
increas
rsv
replic
secret
mitogenactiv
protein
kinas
activ
may
contribut
elev
inflammatori
respons
virusassoci
asthma
mccann
imani
contrast
rsvinduc
wheez
correl
level
nasal
lavag
fluid
elev
influenza
rv
infect
gern
et
al
thu
possibl
infect
induc
regulatori
mechan
suppress
immun
respons
allow
viral
replic
result
increas
inflammatori
respons
altern
infect
may
induc
inflammatori
respons
enhanc
infect
allerg
inflamm
may
subsequ
promot
induct
regulatori
mechan
limit
inflammationinduc
damag
host
tissu
immun
factor
vivo
vitro
studi
shown
rsv
infect
respiratori
epithelium
caus
releas
factor
immun
function
includ
arachidon
acid
metabolit
lt
mediat
releas
eosinophil
chemokin
review
ogra
cell
adhes
home
molecul
eselectin
antigenpres
molecul
includ
human
leucocyt
antigen
class
ii
also
upregul
upon
infect
sever
transcript
factor
also
activ
may
induc
express
rang
gene
nuclear
factor
nf
kb
factor
regul
immunomodulatori
mediat
gmcsf
adhes
molecul
eselectin
chemokin
eotaxin
rant
garofalo
et
al
oh
et
al
john
et
al
makela
et
al
schaller
et
al
combin
mediat
molecul
induc
influx
inflammatori
cell
may
contribut
develop
infectioninduc
inflammatori
immun
respons
ahr
asthma
ineffect
aberr
humor
respons
may
also
role
rsvinduc
asthma
infect
induc
increas
b
cell
number
roman
et
al
product
serum
mucos
igm
iga
igg
antibodi
import
protect
diseas
occur
lower
level
infant
antibodi
respons
primari
infect
ineffect
involv
product
partial
neutralis
antibodi
g
f
protein
respons
reinforc
especi
igg
iga
upon
reinfect
rsvspecif
ige
antibodi
also
produc
welliv
et
al
major
children
increas
amount
persist
promot
develop
wheez
ogra
increas
vascular
angiogenesi
surround
airway
wall
associ
chronic
fatal
asthma
also
mildtomoder
asthma
children
adult
li
wilson
vrugt
et
al
barbato
et
al
suggest
pathogenet
role
stage
asthma
develop
angiogenesi
regul
balanc
proangiogen
vascular
endotheli
growth
factor
vegf
basic
fibroblast
growth
factor
bfgf
angiogenin
chemokin
antiangiogen
endostatin
canstatin
tumstatin
arresten
factor
cohen
vasodil
increas
number
blood
vessel
respons
inflammatori
stimuli
may
lead
edema
inflamm
bronchial
wall
influx
inflammatori
cell
includ
eosinophil
releas
mediat
airway
narrow
ahr
black
page
wilson
salvato
nomura
et
al
elev
level
vegf
bfgf
angiogenin
occur
airway
asthmat
correl
increas
vascular
vessel
permeabl
ahr
hoshino
et
al
kanazawa
et
al
nomura
et
al
felti
et
al
vegf
influenc
vascular
permeabl
format
blood
vessel
fenestr
vasiculovasculo
organel
dvorak
et
al
esser
et
al
neufeld
et
al
vegf
also
stimul
endotheli
cell
prolifer
migrat
matrix
remodel
vasodil
well
inhibit
endotheli
cell
apoptosi
process
involv
angiogenesi
neufeld
et
al
vegf
also
enhanc
sensit
rt
allergen
promot
inflamm
rsv
infect
may
contribut
develop
asthma
induc
product
vegf
angiogenesi
vegf
detect
nasal
wash
rsv
infect
patient
indic
infect
stimul
vegf
product
may
role
diseas
lee
et
al
furthermor
featur
rsv
bronchiol
pneumonia
submucos
adventiti
interstiti
edema
due
alter
blood
vessel
permeabl
brought
vegf
activ
dvorak
et
al
esser
et
al
neufeld
et
al
specif
role
vegf
rsv
infect
intens
investig
releas
airway
epitheli
cell
cell
mucos
fibroblast
upon
infect
lee
et
al
also
produc
monocyt
macrophag
cell
keratinocyt
granulocyt
eosinophil
smooth
muscl
cell
gaudri
et
al
horiuchi
weller
neufeld
et
al
thu
novel
mechan
may
involv
rsvinduc
asthma
wherebi
induct
vegf
upon
infect
may
lead
develop
angiogenesi
enhanc
inflammatori
respons
furthermor
rsvinduc
secret
vegf
may
contribut
exacerb
increas
vascular
permeabl
recur
infect
may
contribut
cycl
vegf
product
promot
angiogenesi
remodel
neurolog
immunolog
interact
occur
result
rsv
infect
also
link
gener
airway
inflamm
ahr
rad
children
excitatori
nonadrenerg
noncholinerg
nerv
nanc
releas
neurotransmitt
includ
substanc
p
particip
earli
phase
inflammatori
respons
also
immunomodulatori
role
piedimont
slough
epithelium
infect
may
lead
exposur
neurogen
receptor
enhanc
proinflammatori
effect
substanc
p
lead
asm
spasm
bronchoconstrict
contribut
respiratori
symptom
nerv
growth
factor
particip
neuron
develop
benefici
effect
inflamm
repair
remodel
howev
suggest
effect
may
becom
pathogenet
rsv
infect
allerg
inflamm
exacerb
inflamm
ahr
nassenstein
et
al
effect
coinfect
rsv
virus
littl
studi
howev
notabl
risk
develop
bronchiol
time
greater
infant
coinfect
rv
papadopoulo
et
al
anim
model
infect
allerg
airway
diseas
aad
develop
use
extens
substanti
contribut
understand
mechan
underpin
rsvinduc
asthma
exacerb
particular
rodent
mous
lesser
extent
rat
bovin
model
use
elucid
mechan
associ
trial
therapeut
agent
vaccin
chimpanze
permiss
human
rsv
best
anim
model
avail
cost
limit
advanc
clinic
test
whitehead
et
al
use
model
import
factor
identifi
may
play
key
role
rsvinduc
asthma
includ
age
first
infect
time
infect
rel
allergen
exposur
induct
asthma
endotoxin
exposur
innat
factor
adapt
immun
suppress
immun
angiogenesi
neural
network
latent
infect
import
differ
viral
protein
infect
also
investig
use
anim
model
enabl
experiment
protocol
conduct
possibl
human
particular
precis
investig
differ
age
infect
combin
time
infect
rel
allerg
sensit
collect
invas
tissu
sampl
achiev
anim
although
problem
model
rsv
challeng
includ
rsv
replic
mice
induc
recruit
granulocyt
observ
human
diseas
model
use
extens
gain
valuabl
insight
mechan
rsvinduc
diseas
mous
model
rsv
infect
induc
signific
acut
respiratori
inflamm
chang
lung
function
high
dose
plaqu
form
unit
pfu
induc
sever
alveol
pneumonia
low
dose
pfu
result
bronchiol
without
effect
dakhama
et
al
five
day
infect
mice
develop
acut
airway
obstruct
correl
progress
inflamm
histopatholog
characteris
intens
perivascular
peribronchialbronchiolar
influx
monocyt
macrophag
neutrophil
lymphocyt
cell
also
occur
alveoli
peak
inflamm
leakag
airway
lumen
absent
jafri
et
al
infect
peak
day
resolv
day
cytokin
chemokin
mip
rant
releas
respiratori
epithelium
alveolar
macrophag
respons
infect
day
nk
cell
influx
balf
replac
day
cell
return
preinfect
level
day
hussel
openshaw
ctl
induc
respons
infect
contribut
extens
peribronchiolar
alveolar
inflamm
associ
diseas
symptom
ostler
et
al
import
viral
clearanc
contribut
patholog
primarili
releas
nk
cell
level
peak
day
low
level
present
howev
produc
lung
within
first
day
rel
level
determin
cours
diseas
kalina
gershwin
play
pivot
role
develop
infectioninduc
ahr
absenc
allergen
exposur
makela
et
al
acut
infect
develop
chronic
diseas
featur
chronic
inflamm
histopatholog
score
ahr
term
enhanc
paus
penh
clearanc
viru
week
infect
penh
noninvas
method
whole
bodi
plethysmographi
use
singl
exposur
spasmogen
determin
overal
level
ahr
airway
jafri
et
al
use
penh
show
airway
obstruct
ahr
remain
day
infect
respect
ahr
correl
chronic
inflamm
persist
alveoli
jafri
et
al
support
concept
rsv
diseas
may
induc
longterm
respiratori
chang
children
stein
et
al
sigur
et
al
howev
studi
need
confirm
measur
lower
airway
resist
use
invas
method
precis
measur
chang
airway
tissu
specif
function
employ
dose
respons
spasmogen
studi
use
method
measur
respiratori
imped
airway
resist
shown
lack
longterm
effect
rsv
infect
lung
function
dakhama
et
al
collin
et
al
infect
also
induc
mucu
hypersecret
central
peripher
airway
acut
chronic
phase
sever
progress
pneumonia
develop
increas
histopatholog
chronic
inflammatori
chang
process
contribut
airway
obstruct
penh
develop
acut
phase
progress
correl
viral
load
balf
agre
observ
made
children
jafri
et
al
intens
inflamm
declin
time
remain
around
airway
vessel
neutralis
monoclon
antibodi
mab
rsv
substanti
decreas
inflamm
diseas
sever
use
mous
model
shown
age
first
infect
play
key
role
shape
domin
immun
respons
later
life
review
hansbro
et
al
establish
subsequ
pattern
th
cell
respons
natur
sever
ensu
respiratori
diseas
culley
et
al
holt
sli
horvat
et
al
primari
rsv
infect
neonat
mice
profil
adult
howev
associ
slower
diminish
respons
develop
persist
cytokin
releas
cell
effect
substanti
revers
protect
effect
mycobacteri
exposur
aad
neonat
rsv
infect
result
earli
releas
longterm
advers
effect
respiratori
system
effect
includ
induct
ahr
perivascular
bronchial
inflamm
subepitheli
fibrosi
exacerb
subsequ
allergen
exposur
involv
persist
express
mucu
hypersecret
et
al
gener
respons
immunolog
develop
profound
modulatori
effect
balanc
subsequ
respons
promot
mark
increas
phenotyp
adulthood
chen
et
al
walzl
et
al
culley
et
al
neonat
bia
may
result
type
cell
dendrit
cell
present
environ
combin
effect
nelson
et
al
gori
et
al
white
et
al
bartz
et
al
subsequ
reinfect
later
life
may
reinforc
aberr
respons
cytokin
cell
alter
respons
allergen
result
enhanc
inflamm
mucu
hypersecret
ahr
allergi
enhanc
weight
loss
cell
eosinophil
recruit
airway
chen
et
al
walzl
et
al
culley
et
al
dakhama
et
al
suggest
aad
adult
prime
infect
neonat
like
caus
factor
promot
respons
culley
et
al
holt
sli
initi
infect
delay
mice
week
age
product
increas
upon
reinfect
although
airway
inflamm
still
occur
subsequ
reduct
sever
diseas
mucu
product
ahr
culley
et
al
dakhama
et
al
thu
delay
age
infect
later
life
may
effect
strategi
prevent
rsvassoci
asthma
anim
model
use
determin
rsv
induc
develop
asthma
trigger
proasthmat
immun
respons
lead
variabl
airflow
obstruct
airway
inflamm
chavezbueno
et
al
demonstr
rsv
induc
acut
chronic
diseas
featur
aad
independ
allerg
sensit
genet
background
mice
rsv
infect
balbc
mice
absenc
allerg
sensit
led
similar
level
acut
airway
inflamm
airflow
obstruct
ahr
degre
airway
inflamm
correl
ahr
immun
respons
surprisingli
similar
two
strain
characteris
virusdepend
releas
importantli
infect
inflammatori
respons
short
live
acut
infect
develop
persist
infect
correl
airway
inflamm
present
day
infect
viru
load
airway
inflamm
greatest
acut
phase
chronic
infect
correl
chronic
inflamm
airflow
obstruct
thu
rsv
infect
initi
acut
event
result
airflow
obstruct
possibl
ahr
chang
persist
beyond
initi
inflammatori
respons
investig
also
shown
rsv
infect
earli
life
act
synergist
atopi
drive
develop
allerg
asthma
holt
sli
kusel
et
al
howev
immunolog
process
involv
induct
allerg
sensit
rsv
infect
like
involv
exacerb
allerg
asthma
rsv
effect
rsv
infect
aad
may
critic
depend
rel
time
infect
allerg
sensit
challeng
peebl
et
al
barend
et
al
barend
et
al
major
studi
mice
show
rsv
augment
aad
howev
convers
investig
suggest
rsv
infect
prevent
atopi
inde
rsv
induc
strong
mediat
respons
may
modul
respons
allergen
peebl
et
al
juntti
et
al
contrast
observ
explain
two
compet
immun
respons
occur
simultan
may
subtli
differ
differ
protocol
develop
allergi
may
depend
phenotyp
immun
respons
allergen
rsv
time
exposur
allergen
exposur
prior
infect
prior
exposur
airway
allergen
independ
allergen
type
predispos
increas
sever
virusinduc
aad
mice
like
play
role
human
peebl
et
al
makela
et
al
kalina
gershwin
infect
enhanc
cytokin
respons
mucu
secret
cell
hypertrophi
eosinophil
influx
lung
ahr
respons
allergen
increas
sever
aad
potenc
respons
elicit
overrid
counterregulatori
effect
respons
typic
induc
infect
randolph
et
al
infect
prior
allergen
exposur
exposur
rsv
infect
mice
rat
allergen
increas
inflamm
mucu
product
ahr
prolong
rsv
replic
peebl
et
al
kalina
gershwin
hassantoufighi
et
al
particular
inflammatori
respons
lung
enhanc
lukac
et
al
barend
et
al
schaller
et
al
block
infect
reduc
chemokin
express
ahr
block
rant
remov
effect
infect
upon
later
allergen
sensit
challeng
lukac
et
al
absenc
cc
chemokin
receptor
defici
mice
lead
reduct
cell
eosinophil
mucu
ahr
john
et
al
observ
suggest
chemokin
receptor
play
role
rsvinduc
aberr
respons
allergen
may
import
mobilis
virusand
allergenspecif
cell
allerg
inflamm
possibl
rsv
infect
may
contribut
develop
allergi
damag
respiratori
mucosa
expos
apc
cell
allergen
may
break
toler
induc
system
sensit
excess
infectioninduc
respiratori
damag
may
occur
predispos
individu
result
defect
cell
mobilis
activ
activ
allergen
challeng
sensit
mice
occur
concomit
infect
inflammatori
respons
enhanc
lead
respons
rsvand
promot
chronic
infect
makela
et
al
product
lead
eosinophilia
releas
mcp
inflamm
enhanc
ahr
rat
sensit
extract
common
household
mould
aspergillu
fumigatu
induc
eosinophilia
cytokin
releas
rsv
infect
allergen
challeng
exacerb
inflammatori
respons
ahr
depend
viral
replic
infect
caus
increas
express
mhc
ii
alveolar
macrophag
may
involv
initi
immun
respons
allergen
persist
infect
induc
relat
reduc
express
suggest
allerg
sensit
affect
progress
rsv
infect
kalina
gershwin
treatment
infect
fumigatu
challeng
anim
recombin
reduc
allerg
respons
cytokin
ahr
suggest
patholog
physiolog
factor
diseas
independ
hassantoufighi
et
al
taken
togeth
studi
suggest
gener
rsv
induc
increas
sever
aad
develop
aad
increas
sever
persist
rsv
infect
report
suggest
exposur
endotoxin
environment
pollut
affect
progress
rsv
infect
gurkan
et
al
monick
et
al
exposur
factor
alter
rel
proport
cytokin
produc
upon
infect
affect
diseas
progress
howev
cellular
molecular
process
involv
understood
express
may
provid
link
rsv
endotoxin
asthma
express
usual
rest
airway
epithelium
requir
high
endotoxin
exposur
upregul
rsv
infect
induc
increas
express
respons
endotoxin
initi
potent
inflammatori
respons
monick
et
al
may
link
human
asthma
endotoxin
also
induc
asthma
exacerb
children
rsvinduc
asthma
park
et
al
anim
model
use
extens
elucid
host
immun
respons
induc
rsv
rt
infect
respons
may
contribut
develop
exacerb
asthma
infect
may
inhibit
modul
activ
innat
adapt
particularli
cell
immun
respons
develop
diseas
may
play
crucial
role
induct
patholog
aad
primari
rsv
infect
induc
innat
respons
involv
eosinophil
neutrophil
influx
lung
result
ahr
cytokin
respons
domin
schwarz
et
al
eosinophil
infiltr
depend
critic
develop
ahr
innat
respons
first
day
also
characteris
influx
nk
cell
produc
replac
adapt
cell
releas
low
level
openshaw
boelen
et
al
van
schaik
et
al
openshaw
cell
respons
facilit
viral
clearanc
also
induc
host
tissu
damag
patholog
infect
induc
innat
respons
involv
tlr
cytokin
chemokin
dc
ultim
direct
develop
adapt
cell
antibodi
respons
durbin
durbin
krishnan
et
al
tlr
rsv
may
use
varieti
host
cell
factor
bind
enter
cell
includ
heparin
caveolin
kalina
gershwin
bind
initi
product
may
respons
initi
respons
infect
howev
role
tlr
virusinduc
asthma
controversi
studi
report
innat
immun
respons
rsv
infect
mice
depend
express
kurtjon
et
al
haeberl
et
al
may
interact
viral
f
protein
openshaw
et
al
anoth
report
argu
opposit
say
signific
role
infect
ehl
et
al
recognis
doubl
strand
ds
rna
constitut
express
respiratori
epitheli
cell
dc
signal
independ
myeloid
differenti
factor
induc
activ
express
activ
lead
apoptosi
elimin
infect
cell
viru
recent
shown
protein
kinas
r
pkr
upregul
human
airway
epitheli
cell
rsv
infect
enhanc
epitheli
respons
activ
may
sensit
cell
subsequ
viral
bacteri
infect
groskreutz
et
al
chemokin
chemokin
produc
stromal
epitheli
immun
cell
regul
immun
respons
chemoattract
leukocyt
lung
inflamm
mucu
product
angiogenesi
although
cellular
inflamm
often
similar
respons
differ
viral
infect
type
chemokin
level
releas
drive
subsequ
immun
respons
differ
substanti
schaller
et
al
primari
rsv
infect
induc
express
chemokin
belong
cxc
cc
rant
eotaxin
cell
activ
c
lymphotactin
famili
lung
express
high
defici
mice
reduc
lung
inflamm
rsv
titr
wildtyp
mice
thu
rsvassoci
lung
inflamm
may
mediat
earli
product
inflammatori
chemokin
haeberl
et
al
dc
dc
import
antigenpres
cell
apc
take
viral
antigen
traffic
local
lymph
node
present
antigen
cell
caus
differenti
effector
cell
dc
direct
innat
adapt
immun
respons
virus
allergen
essenti
allerg
sensit
differ
subset
dc
exist
differ
function
mdc
present
viral
antigen
promot
cell
expans
great
extent
pdc
import
develop
toler
van
rijt
et
al
dc
network
less
activ
infant
anim
enhanc
mdc
increas
upon
viral
infect
holt
sli
zuniga
et
al
possibl
reduct
pdc
convers
mdc
earli
life
viral
infect
may
inhibit
develop
toler
exacerb
allerg
respons
outcom
rsv
infect
may
depend
natur
adapt
respons
balanc
immun
primari
infect
balbc
mice
induc
mix
respons
earli
burst
releas
import
determin
phenotyp
subsequ
respons
openshaw
tregon
adapt
respons
involv
cell
b
cellantibodi
respons
also
play
signific
role
respons
rsv
cell
respons
rsv
infect
typic
induc
robust
respons
elev
level
mice
archetyp
cytokin
releas
signal
receptor
infect
pivot
control
respons
infect
process
essenti
moder
eosinophil
migrat
cell
crucial
viral
clearanc
absenc
domin
respons
induc
eosinophil
influx
lung
ahr
barend
et
al
contrast
absenc
littl
effect
howev
induc
suppress
respons
promot
product
nk
cell
reduc
product
cell
prevent
essenti
inhibit
virusinduc
eosinophil
influx
lung
hussel
openshaw
function
b
cell
exacerb
diseas
mice
sensit
allergen
openshaw
et
al
remov
induct
cell
also
elimin
eosinophil
influx
hussel
et
al
anoth
cytokin
overproduc
viral
rt
infect
exacerb
inflamm
promot
neutrophil
eosinophil
influx
treatment
mice
lead
ablat
weight
loss
ill
without
affect
viral
clearanc
induc
advers
sideeffect
indic
potenti
use
therapi
hussel
et
al
respons
respons
induc
rsv
infect
varieti
anim
model
absenc
may
contribut
develop
aad
respons
potent
similar
respons
observ
allergen
exposur
allerg
individu
bracial
rsvinduc
respons
diminish
respons
develop
rsvinduc
allergi
although
respons
even
greater
absenc
barend
et
al
specif
set
cell
subpopul
induc
superantigen
type
respons
rsv
pivot
induc
mediat
patholog
varga
et
al
surfac
receptor
famili
express
cell
present
subset
cell
mice
rsvinduc
eosinophilia
mab
treatment
reduc
patholog
walzl
et
al
studi
suggest
circumst
infect
may
induc
strong
respons
mechan
lead
aad
unknown
cytokin
releas
respons
like
involv
rsvinduc
aad
mice
primari
rsv
infect
result
increas
level
howev
import
develop
respons
aad
unclear
defici
mice
mice
treat
neutralis
immun
vaccinia
viru
express
protein
g
reduct
pulmonari
eosinophil
cytokin
secret
furthermor
infect
defici
mice
result
enhanc
number
eosinophil
lung
ahr
johnson
et
al
contrast
releas
may
pivot
rsvinduc
respons
aad
infect
mice
result
ahr
eosinophil
influx
lung
associ
strong
respons
critic
mediat
eosinophil
influx
ahr
allergi
schwarz
et
al
defici
lead
reduct
pulmonari
eosinophil
ahr
revers
replenish
treatment
antiveri
late
prevent
influx
eosinophil
lubg
ahr
respons
rsv
infect
replenish
rsv
infect
induc
express
mous
pulmonari
cell
hussel
et
al
absenc
inhibit
develop
ahr
respons
allergen
sensit
challeng
rsv
infect
overcom
defici
induc
eosinophil
infiltr
lung
airway
mucu
product
ahr
associ
increas
respons
makela
et
al
associ
develop
rsvinduc
ahr
may
promot
releas
cytokin
einarsson
et
al
although
requir
develop
mucu
hypersecret
ahr
mous
model
aad
secondari
rsv
infect
infect
neonat
kuperman
et
al
dakhama
et
al
appear
play
import
role
induct
respons
primari
infect
yet
investig
human
like
well
induc
phenotyp
rsv
may
take
advantag
respons
predomin
asthmat
ineffectu
infect
howev
surprisingli
rsv
clearanc
occur
condit
wherebi
eosinophil
take
rsv
inactiv
viru
ecp
soukup
becker
increas
fasl
express
macrophag
cell
therefor
also
antivir
effect
ruan
et
al
cell
target
sever
rsv
protein
suffici
clear
rsv
infect
mice
cannon
et
al
cherri
et
al
howev
clearanc
immunopatholog
still
occur
mice
graham
et
al
adopt
transfer
virusspecif
ctl
home
lung
elimin
rsv
cell
induc
viral
clearanc
perforin
granzymemedi
lysi
virusinfect
cell
aung
et
al
howev
perforin
also
produc
nk
cell
tnf
necessari
releas
crucial
cellmedi
clearanc
rsv
elimin
unchang
kinet
perforin
defici
mice
aung
et
al
ostler
et
al
wherea
treatment
mice
neutralis
antibodi
transfus
effector
ctl
abolish
viru
control
induc
cellmedi
patholog
ostler
et
al
contrast
high
dose
primari
infect
defici
mice
led
attenu
immunopatholog
slightli
delay
clearanc
suggest
cell
molecul
partial
substitut
ctlderiv
driven
viru
clearanc
implic
pivot
immun
factor
rsvinduc
immunopatholog
cellmedi
control
ostler
et
al
cell
may
also
suppress
develop
virusspecif
immun
respons
eosinophilia
although
mechan
effect
remain
unknown
hussel
et
al
show
earli
releas
cell
respons
rsv
infect
mice
result
suppress
respons
hussel
et
al
suppress
respons
cell
studi
srikiatkhachorn
bracial
interestingli
effect
rsv
g
protein
nullifi
incorpor
epitop
onto
g
protein
srikiatkhachorn
bracial
interact
cell
expos
present
viral
antigen
lymph
node
respiratori
tract
induc
differenti
activ
mobilis
effector
memori
cell
memori
cell
move
rsv
infect
rt
prolifer
differenti
cytokin
releas
effector
cell
induc
effect
situ
varga
et
al
varga
et
al
differenti
cell
subject
infectioninduc
modul
like
interact
occur
concurr
similar
interact
may
take
place
allergen
provoc
rt
asthmat
potenti
substanti
affect
cell
phenotyp
effect
may
enhanc
upon
infect
thu
complex
interact
infecti
stimuli
allergen
may
pivot
import
develop
rsvinduc
aad
process
may
target
therapeut
suppress
allergen
specif
respons
lung
differenti
immun
respons
induc
differ
rsv
protein
may
import
develop
exacerb
asthma
protein
g
vaccin
mice
induc
memori
popul
lead
reduc
nk
cell
influx
product
result
induct
respons
absenc
ctl
respons
releas
cell
promot
eosinophilia
upon
subsequ
infect
alwan
et
al
srikiatkhachorn
bracial
walzl
et
al
openshaw
et
al
g
protein
defect
rsv
use
demonstr
protein
crucial
promot
airway
inflamm
reduc
lung
function
schwarz
schauer
f
protein
immun
induc
mixtur
nk
type
mhc
cell
lead
product
reduc
diseas
alwan
et
al
srikiatkhachorn
bracial
openshaw
et
al
nk
cell
releas
regul
induct
prolifer
cell
clear
viru
primari
rsv
infect
induc
expans
activ
restrict
peptid
epitop
rsv
protein
specif
cell
lung
impli
activ
prolifer
cell
precursor
normal
taken
togeth
result
suggest
natur
infect
induc
respons
may
domin
respons
g
protein
exacerb
infecti
allerg
diseas
wherea
respons
f
protein
may
mediat
reduc
diseas
antibodi
respons
may
sever
role
rsvassoci
aad
mice
rsv
infect
may
induc
develop
proallerg
ige
antibodi
receptor
lung
may
induc
mast
cell
degranul
ahr
dakhama
et
al
activ
antivir
protein
kinas
upon
infect
may
lead
isotyp
switch
b
cell
produc
ige
rager
et
al
studi
shown
exposur
allergen
acut
rsv
infect
mice
result
product
antigen
specif
respons
characterist
immun
odonnel
openshaw
moreov
nonneutralis
antibodi
produc
respons
formalininactiv
fi
viru
may
induc
immun
complex
format
lung
openshaw
et
al
may
involv
pathogenesi
infant
poor
cell
independ
antibodi
respons
produc
differ
type
antibodi
compar
adult
earli
life
infect
rsv
may
fix
natur
antibodi
product
well
cell
respons
subsequ
infect
throughout
life
promot
develop
ahr
openshaw
et
al
studi
mice
suggest
rsv
may
promot
infect
suppress
host
immun
result
enhanc
inflamm
rsv
g
protein
may
attenu
innat
respons
bind
valarch
taylor
induct
cytokin
product
monocyt
macrophag
inhibit
mediat
signal
polack
et
al
rsvspecif
cell
may
play
crucial
role
viral
clearanc
limit
evid
suggest
infect
may
suppress
activ
activ
cell
lead
enhanc
viral
replic
diseas
harcourt
et
al
suppress
f
protein
rsv
may
downregul
activ
cell
cytokin
product
includ
releas
kondo
et
al
schauer
et
al
rt
infect
also
suppress
ctl
immun
rapid
loss
virusspecif
memori
cell
releas
chang
bracial
mirror
human
lack
induct
immunolog
memori
effect
may
occur
antigen
receptor
signal
vari
differ
extent
differ
cell
function
ctl
activ
cytokin
releas
may
result
reduc
ctl
activ
allow
viral
persist
may
also
enabl
mainten
cytokin
respons
facilit
virusor
allergenassoci
inflamm
promot
enhanc
diseas
despit
evid
immun
suppress
infect
yet
observ
human
effect
may
present
lung
detect
blood
bracial
unknown
cell
phenotyp
exist
rt
human
sever
rsv
infect
rsv
infect
may
also
attenu
protect
immun
respons
suppress
type
ifn
modul
dc
activ
g
protein
mimicri
chemokin
may
inhibit
cell
migrat
produc
viral
variant
recognis
neutralis
antibodi
tripp
meyer
et
al
viral
element
respons
dysregul
immun
respons
known
persist
rsv
viral
bacteri
infect
local
system
underli
chronic
lung
diseas
may
promot
suscept
rsvinduc
asthma
emerg
evid
mous
human
studi
suggest
rsv
infect
may
persist
low
level
mechan
involv
suppress
immun
avoid
immun
detect
total
clearanc
seemung
et
al
occur
mice
function
neutralis
antibodi
ctl
respons
even
though
viru
possess
epitop
product
infect
reactiv
deplet
cell
mous
model
rsv
detect
cultur
day
infect
pcr
day
independ
genet
background
viral
copi
number
correl
ahr
tripp
chavezbueno
et
al
associ
yet
proven
treatment
neutralis
antibodi
reduc
viral
number
diseas
sever
howev
possibl
viral
detect
pcr
condit
may
repres
persist
viral
debri
follow
administr
high
viral
inocula
may
part
diseas
process
remain
unknown
whether
viral
persist
occur
children
follow
bronchiol
develop
wheez
longterm
pulmonari
abnorm
persist
infect
occur
chronic
inflamm
alter
immun
cytokin
chemokin
respons
may
induc
individu
rsvinduc
aad
thu
persist
infect
may
import
longterm
morbid
may
provid
new
therapeut
target
limit
mous
primat
studi
acut
chronic
asthma
also
link
vegf
pathophysiolog
featur
rsv
infect
asthma
suzaki
et
al
avdalov
et
al
lee
et
al
overexpress
vegf
lung
mice
level
found
asthma
rsv
infect
induc
angiogenesi
oedema
inflamm
vascular
remodel
mucu
cell
hyperplasiametaplasia
ahr
rat
model
rsvinduc
bronchiol
also
develop
rat
rapidli
clear
viru
similar
manner
selflimit
infect
human
infant
piedimont
et
al
model
use
investig
alter
neural
network
rsv
infect
infect
infant
rat
enabl
analysi
effect
earli
life
infect
king
et
al
stronger
neurogen
inflammatori
respons
develop
lrt
infant
rat
adult
rat
infect
may
explain
bronchiol
present
infant
urt
infect
older
subject
induct
inflamm
involv
upregul
infect
lung
express
asm
fibr
activ
nanc
nerv
mediat
substanc
p
induc
immunomodul
neurogen
cellular
inflamm
may
lead
edema
obstruct
king
et
al
piedimont
tripp
et
al
receptor
also
upregul
cell
bronchusassoci
lymphoid
tissu
respons
infect
may
attract
airway
releas
proinflammatori
cytokin
respons
neurogen
stimul
airborn
irrit
recurr
stimul
may
lead
persist
cycl
airway
inflamm
obstruct
inhibit
administr
cgrp
prevent
rsvinduc
ahr
may
potenti
therapeut
target
dakhama
et
al
neurogen
stimul
rsv
infect
also
induc
releas
lt
mast
cell
induc
mucu
secret
weddeb
et
al
anoth
altern
infectioninduc
damag
may
expos
nerv
end
substanc
p
neurokinin
may
mediat
asm
contract
jacobi
investig
shown
rsv
infect
rat
ferret
result
increas
cholinerg
mediat
contract
asm
reduc
inhibitori
nanc
respons
larsen
colasurdo
despit
vast
array
literatur
describ
studi
rsv
infect
anim
model
singl
model
duplic
patholog
featur
diseas
observ
human
infect
major
drawback
studi
rsvinduc
diseas
mice
rsv
natur
mous
pathogen
symptom
induc
upon
infect
minim
compar
observ
human
infant
viru
limit
replic
infect
anim
show
sign
respiratori
ill
domachowsk
et
al
furthermor
larg
dose
viru
requir
primari
infect
rapidli
abort
discrep
human
diseas
mous
model
sever
hamper
investig
rsvinduc
diseas
pneumonia
viru
mice
pvm
closest
genet
rel
rsv
natur
mous
pathogen
easton
et
al
unlik
rsv
pvm
infect
mice
reproduc
mani
acut
inflammatori
respons
describ
rsv
infect
human
pvm
replic
rapidli
induc
inflamm
lead
mucu
plug
airway
overt
sign
diseas
urt
symptom
fatal
pneumonia
depend
administ
dose
easton
et
al
viru
replic
associ
influx
granulocyt
sever
inflammatori
bronchiol
recent
establish
mous
model
rsvlike
diseas
use
pvm
infect
neonat
adult
importantli
neonat
infect
mice
also
exhibit
mani
symptom
observ
rsv
diseas
human
infant
harrison
et
al
rosenberg
et
al
model
utilis
precis
elucid
host
pathogen
relationship
result
rsvinduc
asthma
import
inflamm
induc
diseas
demonstr
inflammatori
respons
remain
activ
cessat
viral
replic
receptor
play
pivot
role
inflammatori
respons
recent
studi
use
pvm
wildtyp
defici
mice
show
differ
clinic
function
histolog
virolog
paramet
investig
indic
pvm
infect
independ
signal
faisca
et
al
antivir
therapi
ribavirin
alon
littl
effect
howev
treatment
ribavirin
combin
antiinflammatori
agent
antagonist
metrant
substanti
reduc
morbid
mortal
follow
infect
rosenberg
et
al
bovin
rsv
pathogenesi
vaccin
develop
recent
review
meyer
et
al
valarch
taylor
bovin
rsv
close
relat
human
rsv
common
caus
lrt
diseas
major
singl
health
problem
calv
worldwid
particularli
winter
stott
et
al
valarch
taylor
inde
epizoot
respiratori
diseas
first
year
life
attribut
bovin
rsv
mortal
typic
reach
outbreak
meyer
et
al
model
bovin
lrt
infect
develop
use
investig
respons
infect
evalu
bovin
vaccin
bovin
rsv
natur
pathogen
pathogen
infect
cattl
share
mani
similar
rsv
infect
human
van
der
poel
et
al
infect
larg
restrict
respiratori
epitheli
cell
caus
littl
cytotox
patholog
mediat
inflammatori
respons
infect
viuff
et
al
valarch
taylor
respons
also
involv
innat
neutrophil
macrophag
recruit
adapt
proinflammatori
cytokin
chemokin
releas
immun
respons
result
respiratori
damag
mechan
patholog
investig
use
genet
manipul
viru
implic
g
sh
protein
infect
f
protein
nonstructur
ns
protein
inflammatori
respons
review
valarch
taylor
pathogenesi
bovin
rsv
transmit
direct
contact
airborn
droplet
possibl
transfer
passiv
human
hall
et
al
mar
et
al
pathogen
infect
rt
much
common
calv
adult
stott
et
al
result
lack
specif
immun
anim
maternallyderiv
antibodi
afford
protect
primari
infect
induc
effect
immun
kimman
et
al
infecti
diseas
take
day
develop
similar
clinic
featur
human
may
possibl
result
persist
infect
valarch
et
al
diseas
urt
induc
mild
symptom
cough
mucu
product
lrt
bronchiol
bronchopneumonia
occur
associ
edema
wheez
dyspnea
verhoeff
et
al
belknap
infect
cattl
induc
inflamm
involv
influx
mononuclear
cell
neutrophil
mix
phenotyp
cell
sometim
eosinophil
peribronchi
region
along
necrosi
apoptosi
epitheli
cell
viuff
et
al
antoni
et
al
ctl
major
role
clearanc
primari
infect
calv
lymphocyt
prolifer
attenu
infect
vitro
kele
et
al
antoni
et
al
wherea
antibodymedi
respons
import
protect
secondari
infect
lumen
airway
becom
occlud
mucu
inflammatori
debri
remodel
event
occur
lead
breath
difficulti
kimman
et
al
viuff
et
al
like
similar
immun
respons
elicit
human
infect
rsv
involv
induct
nfkb
gener
proinflammatori
cytokin
chemokin
interact
viral
compon
f
protein
dsrna
tlr
known
drive
develop
immun
respons
cattl
review
valarch
taylor
human
mice
agerel
differ
immun
respons
infect
cattl
reduc
protect
enhanc
inflammatori
respons
younger
anim
respons
primari
infect
younger
calv
enhanc
fever
virusspecif
releas
pbmc
reduc
peripher
blood
mononuclear
b
cell
virusspecif
iga
neutralis
antibodi
respons
grell
et
al
immunolog
pathogenesi
bovin
rsv
infect
intens
studi
use
revers
genet
engin
viru
less
variabl
human
rsv
result
may
extrapol
human
diseas
collin
et
al
import
role
differ
bovin
rsv
protein
induct
pathogenesi
immun
respons
elucid
use
genet
manipul
virus
g
protein
rsv
major
attach
protein
delet
mutant
replic
absenc
g
protein
vivo
although
replic
unaffect
vitro
karger
et
al
schmidt
et
al
bovin
virus
express
secret
segment
g
protein
also
fold
attenu
replic
fold
higher
mutant
miss
entir
g
protein
teng
et
al
mutant
express
membraneanchor
g
protein
segment
impair
replic
urt
attenu
least
fold
lrt
induc
pathogen
respons
lung
maher
et
al
suggest
fragment
g
protein
import
infect
pathogenesi
secret
portion
play
particularli
signific
role
cleavag
bovin
f
protein
requir
activ
result
product
peptid
tachykinin
virokinin
induc
product
nk
substanc
p
neurogen
proinflammatori
mediat
virokinin
induc
asm
contract
therefor
directli
contribut
airflow
restrict
chemotact
properti
zimmer
et
al
contrast
cleavag
human
rsv
produc
tachykinin
valarch
et
al
delet
variou
part
bovin
f
protein
shown
necessari
prolifer
vivo
defici
mutant
promot
substanti
reduc
airway
inflamm
eosinophil
influx
valarch
et
al
f
protein
respons
suppress
lymphocyt
prolifer
schlender
et
al
howev
effect
express
eosinophil
attract
rant
absenc
f
protein
suggest
mechan
may
involv
suppress
eosinophil
influx
cattl
valarch
et
al
ns
protein
particularli
bovin
rsv
downregul
respons
involv
attenu
irf
schlender
et
al
subsequ
also
shown
human
rsv
spann
et
al
spann
et
al
lo
et
al
lack
ns
protein
result
highli
attenu
replic
lack
pathogenesi
vitro
vivo
whitehead
et
al
valarch
et
al
sh
protein
requir
replic
bovin
rsv
vitro
karger
et
al
replic
attenu
lrt
chimpanze
calv
vivo
whitehead
et
al
valarch
taylor
epidemiolog
studi
wide
link
rsv
infect
develop
bronchiol
wheez
decreas
lung
function
possibl
asthma
childhood
associ
equivoc
later
life
may
depend
sever
infect
may
also
role
rsv
induct
sensit
allergen
allergi
may
predispos
sever
infect
enhanc
sever
symptom
result
infect
may
use
prognost
marker
futur
develop
allerg
diseas
human
anim
studi
investig
mechan
infect
induc
pathogenesi
associ
asthma
age
first
infect
crucial
determin
clinic
outcom
earli
infect
may
promot
develop
proallerg
phenotyp
indic
delay
age
infect
later
life
may
effect
therapeut
strategi
infect
induc
innat
adapt
immun
respons
promot
immun
eosinophil
influx
lung
may
contribut
develop
ahr
time
infect
rel
allergen
exposur
immun
phenotyp
individu
may
signific
determin
effect
infect
interest
novel
concept
rsv
infect
may
induc
develop
angiogenesi
might
exacerb
inflammatori
exud
edema
bronchial
obstruct
asthma
new
hypothes
rsv
may
induc
immun
suppress
allow
viral
persist
latent
infect
reactiv
neural
network
also
potenti
involv
induct
neurogen
inflamm
rv
small
nonenvelop
ssrna
virus
picornavirida
famili
date
differ
serotyp
identifi
savolainen
et
al
epidemiolog
rv
respons
major
case
urt
infecti
diseas
human
particularli
cold
recent
also
implic
caus
signific
number
lrt
infect
rv
also
common
respiratori
viral
pathogen
induc
wheez
age
kusel
et
al
third
episod
acut
respiratori
ill
involv
wheez
children
adult
rv
infect
implic
time
mani
case
virus
wheez
may
progress
develop
asthma
mechan
pathogenesi
rv
much
less
well
understood
rsv
pathogenesi
rv
divid
major
minor
class
base
receptor
bind
properti
major
group
rv
bind
minor
group
virus
bind
lowdens
lipoprotein
receptor
ldlpr
fig
drescher
et
al
bind
rv
ldlpr
induc
conform
chang
capsid
requir
viral
uptak
intracellular
internalis
occur
activ
sphingomyelinas
gener
ceramiderich
membran
raft
facilit
uptak
rv
thought
replic
lrt
howev
possibl
rv
infect
lrt
certain
extent
altern
immun
respons
urt
infect
knockon
effect
inflamm
lrt
infect
urt
typic
caus
coryza
pharyng
viru
detect
fluid
nasopharynx
tonsil
middl
ear
holgat
recent
epidemiolog
studi
correl
rv
asthma
shown
tabl
rv
strongli
link
exacerb
asthma
although
emerg
rv
may
also
import
asthma
induct
strong
associ
rv
infect
childhood
wheez
exacerb
asthma
may
lead
hospit
elsahli
et
al
jartti
et
al
rv
implic
wheez
children
year
age
adult
respons
case
asthma
exacerb
nicholson
et
al
atmar
et
al
freymuth
et
al
tan
interestingli
peak
sever
asthma
exacerb
children
occur
shortli
return
school
break
adult
one
week
later
coincid
peak
rv
infect
spring
fall
longini
et
al
inde
fall
rv
present
children
asymptomat
asthma
exacerb
respect
rsv
may
import
factor
earli
childhood
wheez
major
children
becom
infect
rsv
go
develop
asthma
suggest
factor
import
process
investig
lemansk
et
al
prospect
recruit
cohort
children
risk
asthma
base
famili
histori
follow
year
determin
relationship
viral
infect
symptom
asthma
confirm
infect
episod
etiolog
pcr
nasopharyng
aspir
year
noninfect
factor
exposur
environment
tobacco
smoke
presenc
asthma
older
sibl
igemedi
food
allergi
associ
persist
wheez
rsv
infect
also
link
increas
risk
howev
strongest
independ
predictor
persist
childhood
wheez
episod
rv
infect
associ
wheez
suggest
rv
infect
lemansk
et
al
infanc
associ
develop
asthma
later
life
other
agre
shown
rv
infect
primari
risk
factor
wheez
children
year
atopi
import
thereaft
heymann
et
al
recent
studi
also
indic
recurr
wheez
infant
promot
rv
possibl
greater
extent
rsv
lehtinen
et
al
pathophysiolog
link
rv
asthma
indic
tendenc
children
infect
rv
older
infect
rsv
month
vs
month
increas
frequenc
present
atop
dermat
blood
eosinophilia
korppi
et
al
studi
korppi
et
al
children
hospit
wheez
age
assess
bronchoscopi
prior
median
symptomat
period
month
children
found
asthmat
age
year
atop
earli
predictor
asthma
atop
dermat
specif
ige
inhal
allergi
rv
common
wheez
anoth
recent
studi
infant
age
hospit
bronchiol
identifi
rv
rsv
case
respect
jacqu
et
al
unknown
asthmat
like
develop
cold
greater
risk
sever
cold
corn
et
al
attempt
investig
recruit
coupl
one
asthma
determin
asthmat
risk
develop
cold
found
asthma
like
develop
cold
vs
control
substanti
like
develop
lrt
symptom
associ
cold
vs
impli
viral
infect
asthmat
like
increas
lrt
inflamm
corn
et
al
investig
shown
asthmat
infant
hospit
wheez
greater
chanc
test
posit
rv
nonasthmat
suggest
asthma
suffer
may
also
suscept
infect
xatzipsalti
et
al
furthermor
rv
infect
may
long
last
asthmat
may
persist
week
hospit
acut
asthma
exacerb
rvinduc
ahr
may
also
last
sever
week
kling
et
al
experiment
rv
infect
human
volunt
enabl
studi
effect
infect
immun
respons
lung
function
asthma
well
role
atopi
time
infect
diseas
outcom
infect
upon
bind
rv
greve
et
al
contribut
pathogenesi
also
induct
allerg
inflamm
canonica
et
al
rv
also
induc
upregul
activ
promot
infect
papi
johnston
rv
infect
bronchial
epitheli
layer
mononuclear
cell
fibroblast
increas
airway
inflamm
chang
observ
induc
sputum
endobronchi
biopsi
bronchial
epithelium
asthmat
particularli
suscept
cytotox
effect
virus
papadopoulo
et
al
mosser
et
al
initi
infect
initi
rvinduc
exacerb
cytotox
lead
increas
penetr
effect
allergen
immun
respons
asthmat
nonatop
nonasthmat
inflammatori
chang
involv
almost
type
inflammatori
cell
observ
upon
rv
infect
mild
moder
asthma
infect
induc
increas
level
neutrophil
sputum
promot
influx
eosinophil
mast
cell
cell
airway
wall
enhanc
ahr
fraenkel
et
al
grunberg
et
al
van
benten
et
al
de
kluijver
et
al
show
inflamm
upon
infect
may
less
intens
nonasthmat
although
differ
small
direct
comparison
asthmat
made
time
de
kluijver
et
al
nevertheless
reduc
respons
subject
asthma
may
promot
suscept
infect
invers
correl
level
rv
persist
symptom
asthmat
defici
may
result
either
lack
recruit
appropri
inflammatori
cell
reduc
respons
cell
differ
immun
respons
rv
infect
also
observ
may
involv
increas
suscept
asthmat
infect
enhanc
inflamm
subject
acut
rvinduc
asthma
wark
et
al
found
increas
serum
level
rant
specif
associ
infect
correl
degre
airflow
obstruct
wark
et
al
subject
also
less
bronchodilatori
respons
increas
fev
salbutamol
compar
noninfect
acut
asthma
correl
level
serum
chemokin
bind
import
recruit
cell
infect
tissu
increas
level
activ
mast
cell
caus
migrat
mast
cell
resid
asm
specif
asthma
also
express
therefor
rv
infect
bronchial
epithelium
may
lead
earli
releas
set
chain
event
enhanc
preexist
asthmat
airway
inflamm
promot
migrat
activ
mast
cell
asm
therebi
worsen
bronchoconstrict
reduc
respons
bronchodil
nasal
secret
experiment
infect
healthi
volunt
contain
increas
level
proinflammatori
cytokin
proud
et
al
rv
infect
subject
allerg
rhiniti
asthma
children
virusinduc
asthma
result
elev
level
gcsf
well
increas
blood
nasal
neutrophilia
teran
et
al
gern
et
al
demonstr
rv
infect
worsen
airway
inflamm
obstruct
enhanc
ahr
nonspecif
bronchoconstrictor
subject
asthma
atopi
howev
despit
show
abil
infect
subject
recoveri
viru
signific
exacerb
diseas
observ
grunberg
et
al
treatment
inhal
corticosteroid
icss
effect
reduc
ahr
even
airway
eosinophilia
effect
virusinduc
airway
inflamm
suggest
acut
phase
dispar
featur
diseas
epidemiolog
studi
also
link
rv
infect
reduc
lung
function
exampl
recent
studi
detect
rv
respiratori
epithelium
infant
recur
respiratori
symptom
month
associ
abnorm
lung
function
decreas
airway
conduct
compar
rv
neg
infant
malmstrom
et
al
possibl
serotyp
rv
involv
may
import
strain
particularli
associ
reduc
lung
function
increas
ahr
symptom
asthma
rhiniti
peebl
hartert
determin
whether
atopi
influenc
infect
worsen
ahr
xepadaki
et
al
studi
group
asthmat
children
divid
atopi
xepapadaki
et
al
group
ahr
increas
day
cold
remain
elev
week
group
differ
atop
children
experienc
symptomat
cold
acut
exacerb
lead
cumul
affect
result
persist
ahr
therefor
increas
suscept
atop
infect
demonstr
recur
inflammatori
insult
implic
indirect
caus
sever
ahr
time
infect
rsv
time
infect
rel
allergen
exposur
may
also
import
determin
outcom
rv
infect
asthma
sever
asthma
exacerb
increas
infect
occur
simultan
allergen
exposur
asthmat
green
et
al
howev
infect
allergen
exposur
littl
effect
ahr
de
kluijver
et
al
numer
import
studi
use
varieti
vitro
cell
cultur
system
provid
valuabl
insight
pathogenesi
rv
associ
asthma
specif
role
cytotox
immun
respons
ahr
remodel
involv
angiogenesi
implic
importantli
becom
clear
viral
infect
directli
influenc
lower
airway
inflamm
asthma
asthmat
may
defect
innat
respons
bronchoepitheli
cell
bec
rv
bec
first
point
contact
infect
virus
host
play
import
earli
role
initi
innat
adapt
immun
respons
inflamm
bal
hiemstra
conflict
evid
surround
natur
cpe
rv
infect
epitheli
cell
studi
found
rv
induc
consider
cpe
albeit
serotyp
depend
variat
schroth
et
al
papadopoulo
et
al
other
report
none
littl
cpe
vitro
vivo
winther
et
al
winther
et
al
magnitud
immun
respons
well
differenti
regul
differ
innat
adapt
compon
implic
increas
suscept
asthmat
rv
rvinduc
asthma
exacerb
upon
rv
infect
asthmat
intens
inflammatori
reaction
involv
mucu
product
influx
neutrophil
eosinophil
activ
macrophag
cell
rt
proinflammatori
mediat
releas
associ
sever
persist
lrt
involv
symptom
delay
repair
edward
et
al
inou
et
al
although
similar
cellular
immun
respons
rsv
rv
infect
signific
differ
level
type
cytokin
chemokin
releas
cell
type
produc
ineffect
present
viral
antigen
also
occur
asthmat
may
impair
immun
lead
asthma
symptom
parri
et
al
mani
author
use
epitheli
cell
cultur
model
demonstr
rv
induc
releas
proinflammatori
mediat
possibl
differenti
regul
factor
may
import
rvassoci
asthma
rv
infect
promot
product
oxygen
radic
bronchial
epithelium
lead
increas
express
enhanc
proinflammatori
respons
contoli
et
al
activ
mitogenactiv
protein
kinas
rho
shown
play
import
role
process
dumitru
et
al
rv
infect
human
cell
line
relev
rt
asthma
demonstr
product
mani
differ
proinflammatori
cytokin
chemokin
molecul
induc
includ
eotaxin
gmcsf
rant
subaust
et
al
grunberg
et
al
johnston
et
al
yamaya
et
al
gern
et
al
papadopoulo
et
al
suzuki
et
al
papadopoulo
et
al
hosoda
et
al
konno
et
al
gern
et
al
hall
et
al
edward
et
al
particular
import
increas
product
eotaxin
rant
releas
upon
rv
infect
bec
particip
matur
b
cell
eosinophil
macrophag
chemotaxi
respect
rant
eotaxin
also
power
chemoattractor
eosinophil
drive
airway
eosinophil
inflamm
rant
potent
neutrophil
cell
chemoattract
respect
also
link
reduc
lung
function
experiment
rv
infect
suggest
chemokin
may
involv
asthma
exacerb
grunberg
et
al
importantli
rant
chemokin
releas
greatest
quantiti
bec
infect
rv
wark
unpublish
moreov
bec
treat
dexamethason
inhibit
maximum
dose
although
inhibit
dose
keep
experiment
find
moder
dose
icss
effect
reduc
ahr
infiltr
eosinophil
prevent
accumul
cytotox
cell
therefor
rv
infect
may
induc
neutrophil
cell
influx
may
exacerb
allerg
inflamm
may
refract
ic
treatment
ifn
releas
type
iii
ifn
bec
import
innat
respons
infect
antivir
properti
play
role
apoptosi
infect
cell
direct
adapt
immun
respons
clear
viru
takaoka
et
al
wark
et
al
asthmat
recent
shown
particularli
suscept
develop
rv
lrt
infect
result
reduc
respons
shown
vitro
demonstr
peripher
blood
mononuclear
cell
pbmc
children
adult
asthma
respond
rv
inocul
reduc
releas
corn
et
al
gehlhar
et
al
wark
et
al
establish
model
acut
rv
infect
airway
epithelium
use
primari
bec
pbec
acquir
bronchoscopi
cultur
vitro
asthmat
pbec
allow
significantli
greater
replic
rv
compar
control
innat
respons
asthmat
pbec
rv
defici
releas
wark
et
al
promot
suscept
infect
defect
directli
impair
abil
infect
host
cell
undergo
earli
apoptosi
allow
increas
viru
replic
ultim
cytolysi
infect
cell
defect
result
alter
intracellular
signal
express
viral
internalis
administr
exogen
induc
apoptosi
suppress
viral
replic
identifi
potenti
therapeut
intervent
wark
et
al
releas
mostli
bec
littl
detect
balf
individu
experiment
infect
rv
confirm
import
pathway
provid
microarray
analysi
rvinfect
differenti
bec
identifi
gene
upregul
involv
type
ifn
pathway
express
gene
could
block
mab
dsrna
inhibitor
chen
et
al
rv
infect
pbec
also
induc
releas
novel
immun
mediat
type
iii
interferon
also
antivir
effect
rv
replic
contoli
et
al
group
demonstr
asthmat
pbec
markedli
defici
respons
infect
rv
compar
healthi
volunt
import
earli
respons
infect
confirm
vivo
experiment
rv
infect
volunt
greatest
impair
earli
releas
rv
significantli
increas
viru
replic
sever
cold
symptom
airway
inflamm
sever
fall
lung
function
contoli
et
al
suggest
defect
innat
immun
respons
result
defici
adapt
respons
support
pbmc
asthmat
shown
defici
respons
rv
wark
et
al
other
made
similar
observ
demonstr
time
dose
depend
increas
follow
rv
infect
pbmc
papadopoulo
et
al
cell
normal
subject
produc
higher
level
atop
asthmat
predominantli
produc
papadopoulo
et
al
tlr
recognis
rv
upregul
upon
infect
lead
express
groskreutz
et
al
block
antivir
respons
suppress
rv
replic
releas
hewson
et
al
pkr
releas
promot
gener
proinflammatori
rant
asthmat
may
defici
may
predispos
reduc
immun
respons
increas
persist
rv
infect
may
lead
enhanc
viral
cytotox
hewson
et
al
respons
respons
typic
elev
asthmat
includ
involv
increas
express
airway
epithelium
promot
increas
rv
infect
bianco
et
al
may
particip
eosinophil
cell
influx
lrt
asthma
elev
along
reduc
respons
may
promot
suscept
rv
infect
frequent
viremia
subject
acut
asthma
exacerb
xatzipsalti
et
al
ahrremodel
viral
infect
initi
lower
airway
inflamm
asthmat
appear
suscept
observ
provid
link
infect
increas
sever
ahr
longterm
airway
remodel
infect
pbec
clearli
initi
releas
proinflammatori
mediat
enhanc
recruit
traffick
inflammatori
cell
airway
howev
unknown
whether
affect
remodel
either
directli
influenc
asm
indirectli
affect
featur
remodel
chronic
asthma
determin
rv
infect
could
directli
influenc
remodel
vitro
cultur
model
pbec
fibroblast
subject
mild
moder
asthma
healthi
control
employ
fibroblast
potenti
play
critic
role
remodel
chang
airway
matrix
holgat
et
al
infect
pbec
fibroblast
subject
lead
releas
known
mitogen
factor
cultur
fibroblast
media
taken
pbec
infect
rv
also
induc
releas
mediat
also
increas
express
contractil
protein
alpha
smooth
muscl
actin
may
express
cell
develop
contractil
phenotyp
chang
cellular
morpholog
result
suggest
rv
infect
induc
releas
proremodel
factor
cell
howev
exposur
fibroblast
rv
directli
rv
condit
pbec
media
promot
inflamm
induct
inflammatori
mediat
similar
observ
bec
observ
agre
result
oliv
et
al
demonstr
asthmat
asm
cell
releas
significantli
upon
infect
even
though
viru
replic
cell
oliv
et
al
limit
data
suggest
rv
may
involv
gener
angiogenesi
remodel
infect
induc
releas
vegf
fgf
fibrosi
angiogenesi
induc
factor
primari
airway
epitheli
cell
epithelium
fibroblast
cell
line
factor
also
detect
rvinfect
nasal
secret
ghildyal
et
al
de
silva
et
al
psarra
et
al
volonaki
et
al
psarra
et
al
demonstr
rv
infect
bec
led
induct
vegf
endotheli
cell
treat
medium
infect
bec
began
form
tubul
prolifer
effect
inhibit
antivegf
enhanc
endothelium
expos
cytokin
rv
research
develop
therapeut
strategi
sever
hamper
lack
small
anim
model
investig
diseas
pathogenesi
induct
exacerb
asthma
rv
mice
express
use
receptor
major
group
human
rv
virus
establish
infect
mice
minor
group
rv
howev
infect
airway
epitheli
cell
mice
bind
ldlpr
drescher
et
al
recent
report
newcomb
et
al
describ
mous
model
minor
group
rv
infect
viru
persist
mous
lung
induc
neutrophil
inflamm
airway
involv
express
wherea
major
group
rv
model
sinc
use
demonstr
rv
infect
induc
mucin
product
vivo
mucin
product
model
murin
aad
also
increas
rv
infect
bartlett
et
al
rv
common
caus
common
cold
urt
ill
recent
implic
mani
lrt
episod
rv
infect
also
commonest
caus
wheez
asthma
exacerb
particularli
individu
n
year
age
rvinduc
wheez
may
lead
develop
asthma
recent
evid
suggest
rv
may
import
risk
factor
wheez
asthma
earli
life
case
rsv
asthmat
may
suscept
rv
like
suffer
sever
rv
diseas
vivo
vitro
studi
use
demonstr
rv
infect
exacerb
airway
inflamm
obstruct
ahr
atop
statu
time
infect
may
import
effect
studi
show
magnitud
phenotyp
immun
respons
rv
major
impact
asthmat
outcom
importantli
vitro
studi
identifi
defect
innat
type
iii
ifn
adapt
respons
cell
asthmat
rv
infect
defect
may
promot
suscept
infect
contribut
associ
rv
infect
induct
exacerb
asthma
order
prevent
virusinduc
asthma
exacerb
requir
better
understand
predispos
factor
viral
diseas
associ
causat
exacerb
asthma
develop
effect
antivir
agent
conduct
largescal
prospect
intervent
trial
also
requir
assess
potenti
strategi
prevent
diseas
wennergren
kristjansson
asthmat
rsv
rv
infect
directli
enhanc
airway
inflamm
worsen
airflow
obstruct
much
occur
result
immun
respons
develop
rapidli
upon
infect
exampl
respons
natur
occur
cold
due
rv
infect
result
develop
symptom
within
h
peak
day
resolv
within
week
gwaltney
et
al
rapid
respons
infect
often
rel
mild
symptom
occur
brisk
resolut
determin
difficult
devis
intervent
substanti
clinic
benefit
case
asthmat
acut
exacerb
trigger
viru
infect
clinic
consequ
sever
increas
asthma
symptom
medic
use
emerg
present
hospit
admiss
johnston
et
al
wark
et
al
shown
virusinduc
acut
asthma
worsen
airway
inflamm
degre
inflammatori
respons
directli
relat
sever
acut
clinic
symptom
wark
et
al
therefor
effect
therapeut
intervent
would
need
alter
natur
histori
virusinduc
asthma
prevent
worsen
airway
inflamm
lead
signific
clinic
improv
potenti
therapeut
strategi
problem
discuss
approach
promis
includ
prevent
infect
occur
antivir
agent
elimin
infect
reduc
host
immun
respons
treatment
specif
target
enhanc
inflammatori
respons
induc
virusinduc
asthma
exacerb
supplement
protect
antivir
respons
antioxid
angiogenesi
inhibitor
may
also
benefici
effect
fig
research
inhibit
rsv
rv
infect
may
import
implic
prevent
lrt
infect
develop
exacerb
asthma
human
vaccin
avail
research
requir
develop
effect
antivir
prevent
strategi
specif
antivir
mab
passiv
immun
vaccin
although
evid
antivir
regim
reduc
risk
develop
rad
later
life
scarc
use
antivir
delay
rsv
infect
particular
later
life
may
reduc
subsequ
virusrel
ill
includ
asthma
culley
et
al
genet
factor
fix
investig
intervent
may
develop
reduc
asthma
incid
becom
area
intens
interest
mab
demonstr
efficaci
prevent
rsv
infect
inflamm
anim
model
humanis
mab
palivizumab
rsv
f
protein
effect
rsv
wheez
children
reduc
hospit
highrisk
individu
studi
mice
show
palivizumab
reduc
viral
load
acut
diseas
longterm
lung
function
abnorm
rat
model
palivizumab
inhibit
invas
viru
particl
lrt
epithelium
upregul
receptor
prevent
acut
neurogen
lrt
inflamm
longterm
suscept
inflamm
induc
infect
piedimont
et
al
piedimont
randomis
control
trial
palivizumab
children
achiev
reduct
rsv
hospit
reduct
observ
children
without
chronic
lung
diseas
impact
studi
recent
larg
prospect
casecontrol
studi
risk
preterm
infant
show
palivizumab
also
protect
recurr
wheez
vs
control
physiciandiagnos
recurr
wheez
vs
control
independ
confound
variabl
simo
et
al
one
drawback
escap
mutant
detect
vitro
vivo
zhao
et
al
zhao
sullend
indic
prevent
strategi
target
multipl
epitop
palivizumab
effect
prevent
hospit
highrisk
group
optimis
pharmacokinet
profil
extens
halflif
increas
neutralis
abil
would
produc
even
efficaci
prevent
strategi
rsvassoci
diseas
motavizumab
deriv
palivizumab
clinic
trial
mab
fold
increas
neutralis
abil
vitro
use
reduc
viral
titr
fold
inhibit
viral
replic
rt
compar
palivizumab
rat
wu
et
al
studi
requir
establish
applic
mab
prevent
asthma
mab
also
use
mice
treatment
featur
rsvinduc
diseas
rsv
infect
mice
lead
eosinophil
neutrophil
influx
lung
ahr
inhibit
schwarz
et
al
administr
firsv
lead
decreas
diseas
featur
product
follow
challeng
releas
increas
tang
graham
mab
treatment
reduc
patholog
may
also
good
treatment
walzl
et
al
mab
requir
assess
current
option
prevent
treatment
rsv
passiv
immun
use
mani
year
randomis
placebo
control
trial
investig
applic
rsv
immunoglobulin
prevent
rsvassoci
hospit
prevent
studi
treatment
reduc
hospit
lrt
infect
requir
monthli
administr
high
level
fluid
protein
anoth
small
studi
children
chronic
lung
diseas
treat
immunoglobulin
year
previous
improv
lung
function
reduc
atopi
rad
event
wenzel
et
al
indic
prophylaxi
may
abl
prevent
rad
children
studi
rat
also
show
passiv
transfer
antibodi
rsv
induc
protect
lrt
urt
serum
titr
protect
wherea
titr
princ
et
al
infant
suscept
viru
infect
protect
matern
antivir
antibodi
larg
passiv
transfer
howev
antibodi
inhibit
induct
protect
respons
primari
infect
vaccin
result
primari
recurr
infect
induc
protect
immun
later
life
henderson
et
al
glezen
et
al
natur
protect
viral
diseas
result
combin
antibodi
cellmedi
thelper
cell
immun
combin
respons
target
viru
infect
host
cell
well
destroy
cell
alreadi
infect
viru
therefor
potenti
ideal
vaccin
would
need
stimul
humor
cellular
thelper
respons
similar
induc
natur
infect
vaccin
develop
hamper
requir
earlylif
vaccin
confound
effect
poor
neonat
immun
respons
presenc
matern
antibodi
difficulti
balanc
immunogen
attenu
risk
vaccineinduc
diseas
mucos
immun
may
overcom
immun
suppress
effect
matern
antibodi
fivaccin
wide
recognis
need
effect
rsv
vaccin
also
held
back
advers
event
follow
implement
firsv
vaccin
vaccin
develop
poorli
effect
infam
induc
sever
rsvrelat
diseas
upon
natur
infect
clinic
trial
kapikian
et
al
kim
et
al
vaccin
induc
high
serum
antibodi
titr
low
neutralis
activ
lymphocyt
enhanc
rsvspecif
prolif
respons
blood
eosinophilia
observ
repeat
mice
given
vaccin
g
protein
rsv
enhanc
diseas
involv
eosinophilia
lung
srikiatkhachorn
bracial
tripp
et
al
aberr
cell
releas
cytokin
wari
et
al
srikiatkhachorn
bracial
tripp
et
al
reduc
respons
also
detect
wari
et
al
aung
et
al
fibovin
rsv
also
test
calv
also
induc
develop
immunopatholog
ineffect
neutralis
antibodi
induc
inflammatori
respons
lead
eosinophil
influx
lung
enhanc
ige
product
upon
subsequ
infect
gershwin
et
al
antoni
et
al
kalina
gershwin
case
rsv
mice
fibovin
rsv
induc
longterm
cell
memori
thu
propos
vaccin
possess
suffici
neutralis
antibodi
ctl
respons
subsequ
infect
viru
clear
induc
potent
respons
exacerb
diseas
subunit
vaccin
subunit
vaccin
associ
enhanc
diseas
may
potenti
applic
howev
variabl
human
virus
issu
must
taken
account
develop
subunit
vaccin
rsv
vaccin
f
protein
confer
crossprotect
immun
wherea
groupspecif
immun
develop
g
protein
use
sullend
et
al
simard
et
al
intranas
follow
parenter
immun
rsv
f
protein
protect
upper
lower
rt
infect
mice
may
induc
pulmonari
patholog
murphi
et
al
connor
et
al
walsh
chimer
parainfluenza
viral
vaccin
express
f
protein
also
develop
protect
infecti
challeng
primat
tang
et
al
varieti
differ
human
studi
f
protein
vaccin
shown
immunogen
safe
children
without
chronic
respiratori
diseas
pregnant
women
reduc
preval
infect
lrt
infect
groothui
et
al
munoz
et
al
piedra
et
al
simo
carbonellestrani
meyer
et
al
largescal
trial
requir
confirm
efficaci
protein
gbase
subunit
vaccin
also
develop
may
initi
induc
detriment
respons
immun
respons
involv
activ
follow
immun
vaccinia
viru
express
rsvprotein
g
firsv
must
attenu
modul
protein
gspecif
respons
result
sever
rsvinduc
diseas
howev
inhibit
alon
minim
impact
diseas
johnson
et
al
coadministr
cytokin
adjuv
may
abolish
initi
respons
neuzil
et
al
novel
subunit
vaccin
develop
includ
n
protein
chimer
f
g
fusion
protein
synthet
peptid
recombin
protein
recombin
vaccinia
parainfluenza
virus
express
viral
compon
dna
vaccin
review
meyer
et
al
subunit
vaccin
requir
coadministr
adjuv
enhanc
immunogen
induc
desir
immun
respons
current
quillaja
saponi
compon
fraction
cpg
oligodeoxynucleotid
administ
whole
subunit
vaccin
induc
potent
neutralis
antibodi
desir
immun
respons
mice
reduc
diseas
infect
calv
occur
even
presenc
matern
antibodi
particularli
present
immunostimul
complex
meyer
et
al
howev
applic
approach
human
remain
unknown
live
attenu
vaccin
natur
infect
predispos
enhanc
diseas
upon
subsequ
infect
therefor
experiment
live
attenu
virus
develop
rsv
karron
et
al
intranas
administr
first
day
life
immunolog
underli
activ
poorli
understood
intranas
deliveri
would
induc
system
local
respons
potenti
promot
protect
respons
upper
lower
airway
infant
month
limit
immun
respons
viral
glycoprotein
highli
attenu
viru
strain
minim
advers
sideeffect
use
age
group
particularli
suscept
vaccinerel
ill
agent
howev
induc
protect
immun
even
presenc
passiv
acquir
antibodi
mice
chimpanze
depend
respons
crow
et
al
sever
cold
passag
temperatur
sensit
attenu
virus
develop
protect
challeng
chimpanze
induc
protect
local
system
immun
children
crow
et
al
karron
et
al
virus
sinc
genet
engin
suffici
attenu
use
infant
although
efficaci
infect
yet
determin
karron
et
al
genet
engin
also
current
use
delet
nonessenti
viral
gene
produc
live
attenu
vaccin
insert
gene
enhanc
immun
respons
exampl
insert
gmcsf
increas
product
pdc
macrophag
review
mayer
et
al
assess
attenu
virus
induc
potent
protect
immun
respons
neglig
sideeffect
requir
extens
time
consum
expens
clinic
trial
novel
primeboost
vaccin
strategi
live
attenu
subunit
vaccin
could
use
combin
enhanc
protect
immun
bovin
vaccin
problem
appli
human
rsv
vaccin
may
also
occur
develop
vaccin
calv
farm
industri
level
risk
trial
accept
vaccin
develop
also
less
complex
bovin
rsv
less
variabl
human
rsv
major
antigen
group
prozzi
et
al
led
commerci
sever
vaccin
protect
infect
calv
develop
may
applic
human
vaccin
cattl
may
use
anim
model
preclin
human
vaccin
studi
howev
differ
bovin
model
use
differ
concentr
viral
inocula
rout
inocul
passag
viru
induc
sever
diseas
thu
result
often
compar
signific
experiment
control
group
mayer
et
al
inactiv
bovin
rsv
vaccin
avail
mani
year
reduc
preval
sever
subsequ
infect
without
enhanc
diseas
west
et
al
nevertheless
longev
induc
protect
efficaci
background
matern
antibodi
could
improv
vaccin
coadminist
stimul
adjuv
order
dampen
respons
may
induc
vaccin
lead
protect
respons
elli
et
al
live
attenu
bovin
rsv
vaccin
develop
passag
viru
cell
cultur
recent
commerci
vangeel
et
al
unlik
fivaccin
live
attenu
vaccin
induc
prime
memori
cell
respons
reduc
pulmonari
inflamm
upon
subsequ
infect
miao
et
al
administ
parenter
equival
efficaci
inactiv
vaccin
induc
protect
immun
calv
elli
et
al
vaccin
use
quadrival
therapi
protect
number
bovin
virus
salt
et
al
although
effect
cattl
inactiv
attenu
bovin
rsv
suitabl
vaccin
human
rsv
induc
protect
chimpanze
thu
current
safe
effect
human
vaccin
rsvor
rvand
yet
determin
delay
prevent
infect
neutralis
antibodi
vaccin
reduc
wheez
longterm
lung
function
abnorm
asthma
nevertheless
mani
promis
approach
candid
use
develop
vaccin
human
clinic
trial
prevent
infect
success
may
use
attempt
inhibit
develop
asthma
balanc
immun
infect
determin
sever
diseas
respons
mediat
clearanc
recoveri
respons
induc
eosinophilia
sever
symptom
strategi
augment
respons
vaccin
earli
life
may
use
prevent
develop
virusinduc
asthma
recent
effort
concentr
develop
combin
subunit
vaccin
adjuv
develop
live
attenu
vaccin
promis
approach
develop
vaccin
young
infant
use
live
attenu
vaccin
recombin
virus
express
compon
target
virus
effect
treatment
rsvrvinduc
diseas
current
optim
therapi
bronchiol
involv
intens
fluid
nutrit
support
immun
respons
subject
clear
infect
jhawar
order
maxim
chanc
success
treatment
antivir
agent
would
need
taken
earli
cours
infect
order
modul
develop
host
immun
respons
would
highli
effect
control
infect
viru
would
need
least
limit
abil
develop
resist
final
agent
must
accept
patient
term
eas
administr
reason
medic
frequenc
limit
sideeffect
current
agent
interest
inhibit
viral
attach
includ
bind
viral
capsid
inhibitor
viral
proteas
requir
viral
replic
caus
infect
respiratori
virus
need
enter
host
bec
replic
nineti
percent
rv
use
receptor
enter
cell
solubl
molecul
tremacamra
develop
test
competit
bind
inhibitor
randomis
control
trial
experiment
rv
cold
use
either
dri
powder
nasal
spray
turner
et
al
treatment
result
small
reduct
symptom
viru
replic
develop
clinic
cold
seriou
advers
event
medic
taken
six
time
day
effect
use
within
h
infect
use
therapi
acut
asthma
rv
outer
capsid
consist
viral
protein
rossmann
et
al
sever
agent
devis
bind
prevent
viru
attach
host
cell
first
agent
produc
oxazolinyl
isoaxol
small
clinic
effect
unaccept
sideeffect
develop
led
pleconaril
agent
broad
spectrum
activ
rv
oral
prepar
taken
twice
daili
hayden
et
al
pleconaril
assess
two
phase
ii
clinic
trial
determin
efficaci
natur
cold
hayden
et
al
subject
began
treatment
day
cold
symptom
commenc
take
pleconaril
reduc
cold
symptom
durat
cold
day
sideeffect
applic
us
fda
approv
use
clinic
cold
unsuccess
consid
lack
substanti
clinic
benefit
concern
develop
resist
rv
mutant
stage
clinic
trial
specif
assess
efficaci
pleconaril
acut
asthma
rv
reli
upon
proteas
cleav
viral
polyprotein
replic
occur
rupintrivir
proteas
inhibitor
target
process
dragovich
et
al
highlevel
antivir
activ
rv
dragovich
et
al
binford
et
al
unfortun
natur
infect
studi
ruprintrivir
fail
improv
symptom
reduc
viral
load
clinic
develop
ceas
patick
et
al
antiinflammatori
treatment
therapeut
potenti
virusassoci
diseas
includ
asthma
moder
inflammatori
respons
respons
infect
longterm
treatment
asthma
icss
control
airway
inflamm
junip
et
al
improv
lung
function
symptom
reduc
risk
acut
exacerb
adam
et
al
icss
effect
control
chronic
asthma
complet
prevent
acut
exacerb
even
achiev
good
control
compliant
therapi
major
episod
trigger
viral
infect
reddel
et
al
attempt
prevent
recurr
virusinduc
wheez
infant
treat
intermitt
ic
placebo
symptom
occur
bisgaard
et
al
treatment
clinic
effect
acut
episod
wheez
influenc
whether
children
went
develop
persist
wheez
bisgaard
et
al
anoth
studi
show
treatment
acut
asthma
increas
ic
dose
also
prevent
worsen
diseas
fitzgerald
et
al
incomplet
effect
ic
control
virusinduc
asthma
demonstr
best
adult
asthmat
use
experiment
rv
infect
grunberg
et
al
treatment
reduc
ahr
airway
inflamm
prior
infect
effect
develop
inflammatori
chang
associ
infect
grunberg
et
al
systemat
review
glucocorticoid
suggest
littl
effect
rsv
diseas
black
also
enhanc
viral
replic
mortal
pvm
infect
rosenberg
et
al
oral
corticosteroid
use
treat
acut
viral
bronchiol
children
howev
metaanalysi
seven
randomis
control
trial
found
effect
length
stay
clinic
symptom
complic
patel
et
al
asthmat
persist
symptom
despit
ic
use
treatment
combin
therapi
icss
laba
effect
control
chronic
symptom
reduc
frequenc
exacerb
walter
et
al
recent
shown
earli
treatment
symptom
worsen
asthma
ic
laba
laba
rapid
onset
action
use
reliev
symptom
prevent
deterior
lead
sever
exacerb
obyrn
et
al
studi
identifi
caus
acut
trigger
like
major
relat
viru
infect
combin
icslaba
appear
effect
icss
alon
prevent
exacerb
vitro
studi
demonstr
treatment
airway
epitheli
cell
icslaba
synergist
addit
effect
reduc
releas
inflammatori
mediat
observ
may
explain
efficaci
combin
therapi
indic
import
role
use
may
particularli
relev
children
valu
control
chronic
asthma
well
defin
ahr
known
persist
follow
viral
infect
xepapadaki
et
al
remain
unknown
effect
icslaba
treatment
specif
prevent
treat
virusinduc
asthma
recent
recognis
macrolid
antibiot
addit
antimicrobi
action
import
immun
modul
effect
reduc
releas
inflammatori
mediat
airway
epitheli
cell
takizawa
et
al
epitheli
cell
infect
rv
treat
erythromycin
show
reduc
express
jang
et
al
initi
clinic
studi
howev
promis
use
experiment
rv
infect
treatment
healthi
subject
clarithromycin
littl
effect
develop
cold
symptom
nasal
inflamm
abisheganaden
et
al
howev
unlik
cold
host
inflammatori
respons
airway
rel
mild
condit
characteris
intens
neutrophil
inflamm
cystic
fibrosi
macrolid
appear
effect
ferrara
et
al
encourag
use
asthma
small
randomis
control
trial
infant
rsv
bronchiol
treatment
clarithromycin
reduc
system
inflamm
acut
led
wheez
episod
follow
month
tahan
et
al
larg
multicentr
studi
adult
asthma
subject
randomis
receiv
ketolid
telithromycin
mgd
placebo
johnston
treat
telithromycin
greater
reduct
asthma
symptom
score
differ
group
term
improv
pef
rate
trial
document
presenc
viru
infect
result
suggest
effect
due
abil
reduc
inflamm
acut
asthma
studi
requir
determin
specif
effect
virusinduc
acut
asthma
type
ifn
known
play
crucial
role
defenc
virus
induc
antivir
protein
pkr
rnase
l
infect
cell
apoptosi
prevent
viru
replic
adapt
immun
respons
infect
malmgaard
recent
observ
wark
et
al
asthmat
bec
suscept
infect
rv
involv
defici
respons
suggest
may
import
therapeut
target
limit
affect
virusassoci
acut
asthma
wark
et
al
sever
trial
also
assess
role
treatment
iud
intranas
experiment
rv
cold
healthi
volunt
scott
et
al
hayden
gwaltney
studi
consist
show
dose
depend
improv
symptom
score
reduc
viru
shed
treatment
associ
nasal
bleed
lymphocyt
nasal
infiltr
similar
respons
observ
recombin
sperber
et
al
use
treat
natur
cold
reduc
frequenc
cold
best
modest
effect
symptom
monto
et
al
serin
fail
reduc
cold
improv
symptom
modest
improv
provid
proof
concept
clinic
benefit
difficult
justifi
healthi
individu
mild
cold
howev
case
use
macrolid
asthma
clinic
effect
cold
much
greater
corn
et
al
efficaci
may
evid
singl
case
seri
exist
use
iud
treat
stabl
corticosteroid
resist
asthmat
simon
et
al
treatment
result
improv
lung
function
allow
reduct
oral
corticosteroid
use
howev
sideeffect
also
common
first
week
subject
experienc
flulik
ill
nausea
develop
headach
month
sideeffect
less
though
subject
develop
leukopenia
sever
enough
necessit
temporarili
ceas
treatment
benefit
type
ifn
need
assess
context
treatment
virusassoci
acut
asthma
import
issu
need
resolv
includ
optimum
deliveri
medic
whether
administr
nose
airway
soon
treatment
need
commenc
follow
develop
cold
symptom
may
influenc
airway
inflamm
ahr
acut
asthma
oxid
stress
may
plan
import
role
asthma
unknown
whether
import
virusinduc
diseas
antioxid
butyl
hydroxyanisol
use
mous
model
rsv
lung
infect
reduc
rsvinduc
oxid
stress
diseas
symptom
weight
loss
ahr
effect
mediat
suppress
neutrophil
infiltr
cytokin
chemokin
releas
lung
castro
et
al
thu
antioxid
may
prevent
rsvinduc
inflamm
longterm
benefici
effect
may
amelior
consequ
infect
asthma
use
vegf
angiogenesi
inhibitor
may
potenti
elucid
specif
role
factor
asthma
identifi
potenti
therapeut
target
efficaci
vaccin
yet
exist
prevent
rsv
rv
infect
human
effect
bovin
rsv
vaccin
avail
formul
vaccin
may
applic
develop
human
vaccin
combin
therapi
icss
laba
effect
control
persist
symptom
number
exacerb
current
best
treatment
option
treat
caus
diseas
use
prevent
develop
diseas
first
instanc
varieti
novel
option
prevent
virusinduc
asthma
need
fulli
assess
efficaci
applic
rsv
rv
infect
respiratori
epithelium
may
play
import
role
develop
exacerb
asthma
howev
pivot
mechan
underpin
relationship
remain
unresolv
infect
associ
persist
wheez
decreas
lower
lung
function
worsen
airway
inflamm
airflow
obstruct
acut
asthma
factor
contribut
sever
asthmat
predispos
respons
may
suscept
infect
experi
sever
lrt
symptom
upon
infect
develop
sever
diseas
may
identifi
peopl
risk
develop
wheez
asthma
recur
infect
may
lead
cycl
inflamm
repair
worsen
airway
remodel
rsv
infect
strongli
link
develop
exacerb
asthma
earlylif
rsv
infect
particularli
induc
sever
diseas
induc
recurr
wheez
bronchial
obstruct
predispos
rad
potenti
asthma
persist
later
life
possibl
persist
infect
affect
develop
lung
immun
system
predispos
recur
rsv
infect
ahr
reduc
lung
function
respiratori
symptom
anoth
altern
children
reduc
lung
function
genet
suscept
aberr
immun
respons
may
increas
risk
infect
rsv
diseas
marker
suscept
increas
respiratori
symptom
process
may
occur
differ
circumst
associ
rsv
inconclus
allerg
sensit
may
involv
igemedi
allergi
randomis
intervent
studi
requir
confirm
link
mechan
involv
rsvinduc
asthma
includ
age
first
infect
time
infect
rel
allerg
sensit
natur
innat
adapt
immun
respons
induc
upon
infect
latent
infect
potenti
involv
pathogenet
process
angiogenesi
neurogen
inflamm
combin
human
studi
mous
model
wide
use
elucid
mechan
rsv
infect
link
asthma
novel
model
pvm
infect
may
particularli
use
futur
rv
wide
recognis
commonest
caus
clinic
signific
rt
infect
strongli
implic
exacerb
asthma
recent
induct
asthma
mechan
associ
investig
human
studi
vivo
vitro
shown
involv
defici
immun
respons
may
differ
associ
rsv
may
influenc
atopi
reduc
lung
function
ahr
remodel
nevertheless
work
need
elucid
role
rv
lrt
diseas
remain
unknown
rv
induc
develop
wheez
asthma
asthmat
suscept
rv
infect
recent
novel
mous
model
describ
may
use
substanti
contribut
understand
rv
rvassoci
asthma
pathogenesi
despit
scope
problem
caus
respiratori
virus
acut
asthma
specif
vaccin
treatment
exist
shown
modifi
clinic
outcom
rsv
rv
infect
optim
approach
would
develop
safe
effect
prevent
strategi
efficaci
vaccin
induc
immun
respons
prevent
viral
infect
absenc
vaccin
differ
process
involv
gener
virusassoci
asthma
exacerb
could
target
specif
treatment
individu
patient
sever
therapeut
option
avail
emerg
studi
focu
establish
treatment
icslaba
may
modifi
virusassoci
acut
asthma
assess
novel
antiinflammatori
strategi
includ
macrolid
use
ifn
either
alon
combin
influenc
cours
diseas
benefit
strategi
need
assess
context
treatment
virusassoci
acut
asthma
import
issu
need
resolv
includ
optimum
deliveri
medic
includ
whether
intranas
directli
airway
necessari
determin
soon
treatment
need
commenc
follow
develop
cold
symptom
may
influenc
airway
inflamm
ahr
acut
asthma
summari
although
rsv
rv
implic
initi
inflamm
asthma
whether
previou
infect
modul
immunolog
respons
damag
airway
epithelium
promot
progress
chronic
diseas
suscept
later
develop
exacerb
remain
unknown
asthmat
may
impair
antivir
innat
respons
defect
interact
innat
adapt
immun
respons
may
promot
infect
enhanc
allerg
inflamm
ahr
decreas
lung
function
studi
requir
elucid
link
infect
immun
respons
suscept
chronic
respiratori
diseas
individu
other
develop
persist
wheez
asthma
like
primari
defici
respiratori
epithelium
predispos
infect
asthma
may
exacerb
recur
exposur
environment
insult
wide
recognis
need
understand
mechan
induc
diseas
develop
effect
vaccin
treatment
